English|صفحه اصلی  | سایت اصلی دانشگاه |   امروز: چهارشنبه ٠٦ اسفند ١٣٩٩

آمار بازدید

بازديدکنندگان امروز : 702
بازديدکنندگان این صفحه: 790
کل بازديدکنندگان : 687005
بازديدکنندگان آنلاين : 1
آخرین بروزرسانی : 1399/12/04

Title Row
Convalescent Plasma for COVID-19: back to the future 2730
A Case Report of Neonatal Acute Respiratory Failure Due to SARS-CoV-2 2732
A comprehensive comparative phylogenomics and demographic evolutionary history of the SARS-CoV-2 2733
A first review to explore the association of air pollution (PM and NO2) on severe acute respiratory  syndrome coronavirus (SARS-CoV-2). 2734
A flexible, multi-faceted profession: Supporting frontline practitioners in the fight against COVID-19 2735
A Framework for Aging-Friendly Services and Supports in the Age of COVID-19 2736
A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation 2737
A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2 2738
The art of medicine A history of the medical mask and the rise of throwaway culture 2739
A Pathologic Perspective of COVID-19: Parallels with Severe Influenza Virus Pneumonia. 2741
Novel Coronavirus (COVID-19) and Dentistry–A Comprehensive Review of Literature 2742
Novel coronavirus and regular physical activity involvement: Opinion 2743
Obesity and Outcomes in COVID-19:When an Epidemic and Pandemic Collide 2744
Oedipus and the Coronavirus Pandemic 2745
Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics 2746
On Becoming a Plague Doctor 2747
On coughing and airborne droplet transmission to humans 2748
On the heterogeneity of infections, containment measures and the preliminary forecast of COVID-19 epidemic 2749
On going COVID-19 Global Crisis and Scientific Challenges 2750
Optimization of the CDC Protocol of Molecular Diagnosis of COVID-19 for Timely Diagnosis 2751
Outpatient strategies and the changing SARS-CoV-2 epidemic 2752
Overwhelming COVID-19 Clinical Trials: Call for Prospective Meta-analysis 2753
Pandemic as Teacher — Forcing Clinicians to Inhabit the Experience of Serious Illness 2754
Pandemic Palliative Care Consultations Spanning State and Institutional Borders 2755
Participating in telehealth is a complex occupation 2756
Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin- converting enzyme 2 2757
Pediatric Asthma & Coronavirus (COVID-19)-Clinical Presentation in an Asthmatic Child—Case Report 2758
Personal protection and delivery of rhinologic and endoscopic skull base procedures during the COVID-19 outbreak 2759
Personal Protective Equipment and Covid-19 2760
Physiologic RNA Targets and Refined Sequence Specificity of Coronavirus EndoU 2761
Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA‐dependent RNA polymerase (RdRp) inhibition: An in-silico analysis 2762
New onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 in a London community and secondary care population 2763
Position Statement from the National Centre for Infectious Diseases and the Chapter of Infectious Disease Physicians,Academy of Medicine, Singapore – 23 May 2020 2764
Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients’ B cells 2765
Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19 2766
Potential specific therapies in COVID-19 2767
Prediction of the coronavirus epidemic prevalence in quarantine conditions based on an approximate calculation model 2768
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis Running Head: Predictors of mortality in hospitalized COVID-19 2769
Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19 2770
Prevention of COVID-19 in patients with IBD 2771
Prophylactic treatment protocol against the severity of COVID-19 using melatonin 2772
Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID‑19) 2773
raaS inhibitors do not increase the risk of CoVid-19 2774
Rapid quantification and neutralization assays for novel coronavirus SARS-CoV-2 using Avicel R RC-591 semi-solid overlay 2775
Reactivation of SARS-CoV-2 after Recovery 2776
Recent Discovery and Development on SARS-CoV-2: A Review of Current Literature 2777
Relationship between odor intensity estimates and COVID-19 prevalence prediction in a Swedish population 2778
Remdesivir for the Treatment of Covid-19 — Preliminary Report 2779
Remdesivir: Review of pharmacology, pre-clinical data and emerging clinical experience for COVID- 19 2780
Replication of SARS-CoV-2 in human respiratory epithelium 2781
Repositioning PARP inhibitors for SARS-CoV-2 infection (COVID-19); a new multi- pronged therapy for ARDS? 2782
Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review 2783
Repurposing of Miglustat to inhibit the coronavirus Severe Acquired Respiratory Syndrome SARS-CoV-2 2784
Respiratory virus infections: Understanding COVID-19 2785
Response to ‘To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic’ by Parperis  2786
Response to “Comments on "Homologous recombination within the spike glycoprotein of the newly  identified coronavirus may boost cross-species transmission from snake to human” and “Codon bias analysis alone is uninformative for identifying host(s) of new  2787
Resuming elective surgical services in times of COVID-19 infection 2788
Rethinking Financial Contagion: Information Transmission Mechanism during the COVID-19 pandemic. 2789
Revisiting vitamin D and home-based exercises for patients with sleep apnea facing the COVID-19 quarantine 2790
Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019 2791
Safety and role of chest CT in COVID-19 patients 2792
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial 2793
SARS-CoV-2 detection with CRISPR diagnostics 2794
SARS-CoV-2 infection protects against rechallenge in rhesus macaques 2795
Septic shock presentation in adolescents with COVID-19 2796
Severe Acute Lung Injury Related to COVID-19 Infection:A Review and the Possible Role for Escin 2797
Severity of COVID-19: The importance of being hypertensive 2798
Shared sanitation and the spread of COVID-19: risks and next steps 2799
Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces 2800
Six tips fordata sharing in the age of the coronavirus 2801
Slower COVID-19 morbidity and mortality growth at higher solar irradiance and elevation 2802
Stay-at-Home Orders and COVID-19 Fatalities 2803
Strategies for follow up after hernia surgery during COVID 19 Pandemia. Editorial 2804
Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2 2805
Successful prevention and screening strategies for COVID-19: focused on patients with hematologic diseases 2806
Suicide prevention during the COVID-19 outbreak 2807
Surgical Practice in the Current COVID-19 Pandemic: A Rapid Systematic Review 2808
Systematic Analysis of ACE2 and TMPRSS2 Expression in Salivary Glands Reveals Underlying Transmission Mechanism Caused by SARS-CoV-2 2809
Tale of three seeding patterns of SARS-CoV-2 in Saudi Arabia 2810
Temporal Changes in Immune Blood Cell Parameters in COVID-19 Infection and Recovery from Severe Infection 2811
The application of DNA nucleotide footprint plotting in Coronavirus 2812
The association between severe COVID-19 and low platelet count: evidence from 31 observational  studies involving 7613 participants 2813
The COPD Foundation Coronavirus Disease 2019 International Medical Experts Survey: Results 2814
The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction 2815
The Distributional Impacts of Early Employment Losses from COVID-19 2816
The eye as the discrete but defensible portal of coronavirus infection 2817
The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells 2818
The forced cancellation of four jewel events amidst COVID-19 and its probable influence on the Western Cape economy: A literature review 2819
The immunology of COVID-19: is immune modulation an option for treatment? 2820
The Italian paediatric society raccomandations on children and adolescents extra-domestic activities during the SARS COV-2 emergency phase 2 2821
The Pandemic of Novel Coronavirus Disease 2019 (COVID-19): Need for an Immediate Action 2822
The Possible Role of Vitamin D in Suppressing Cytokine Storm and Associated Mortality in COVID-19 Patients 2823
The Psychological Impact of Confinement Linked to the Coronavirus Epidemic COVID-19 in Algeria 2824
The psychology of coronavirus fear: Are healthcare professionals suffering from corona-phobia? 2825
The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study 2826
The Role of Non-Contrast Chest CT in Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) Pediatric Patients 2827
The simulated net-benefit of PCR test for COVID-19 among asymptomatic patients 2828
The sprint to solve coronavirusprotein structures— and disarm them with drugs 2829
Thinking outside the Box: Could there be a Plant-Based Treatment for Coronavirus Infections? A Review of the Literature 2830
This is the hard-to-swallow truth about a future coronavirus vaccine (and yes, I'm a doctor) 2831
Three kinds of treatment with Homoharringtonine, Hydroxychloroquine or shRNA and their combination against coronavirus PEDV in intro 2832
Three months of COVID-19: A systematic review and meta- analysis 2833
Tiger team: a panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes 2834
Time to step up: A call to action for the clinical and quantitative pharmacology community to accelerate therapeutics for COVID-19 2835
Time-Out Protocol to Ensure Understanding and Implementation of the Storm of Instructions and Protocols During the COVID-19 Pandemic 2836
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic 2837
Toward understanding the 2019 Coronavirus and its impact on the heart 2838
RT-PCR for SARS-CoV-2: quantitative versus qualitative 2839
Sepsiste Sağ Kalım Kampanyası: Coronavirüs Hastalığı 2019 (COVID-19)’ lu Erişkin Kritik Hastalıkların Yönetim Kılavuzu 2840
Traces of SARS-CoV-2 RNA in the Blood of COVID-19 Patients 2841
Tracheotomy in COVID-19 patients: Optimizing patient selection and identifying prognostic indicators 2842
Type 1 diabetes and technology at time of COVID -19. A case report 2843
Understanding Demand for COVID-19 Antibody Testing 2844
Universal Masking in Hospitals in the Covid-19 Era 2845
Analysis:We Knew The CoronavirusWas Coming,YetWe Failed 5 Critical Tests 2846
The girl who died twice Juliet Daly was a healthy 12-year-old in Covington, La., until the coronavirus infected her heart, making its electrical signals go haywire and stop working 2847
Virus ‘does not spread easily’ from contaminated surfaces or animals, revised CDC website states 2848
Cognitive Ability and Vulnerability to Fake News 2849
8 ways to go out and stay safe during the coronavirus pandemic People are starting to leave their homes again. Here’s how to do that and stay as safe as possible. 2850
Updates on coronavirus (COVID-19) and kidney 2851
Using the internet search data to investigate symptom characteristics of COVID-19: a big data study 2852
Vaccines and IP Preparedness in the Coronavirus Outbreak 2853
Viraland host factors related to the clinical outcome of COVID-19 2854
Vitamin-D and COVID-19: do deficient risk a poorer outcome? 2855
Vitamin D concentrations and COVID-19 infection in UK Biobank 2856
Vitamin D supplementation could possibly improve clinical outcomes of patients infected with  coronavirus-2019 (COVID- 2019) 2857
Vitamin D: A Low-Hanging Fruit in COVID-19? 2858
Vitamin D and Inflammation: Potential Implications for Severity of Covid-19 2859
What is the performance and impact of disposable and reusable respirators for healthcare workers in the context of COVID-19? 2860
What Solid Organ Transplant Healthcare Providers should know about Renin-Angiotensin- Aldosterone System Inhibitors and COVID-19 2861
When does a major outbreak become a Public Health Emergency of International Concern? 2862
When Second Best Might be the Best: Using Hospitalization Data to Monitor the Novel Coronavirus Pandemic 2863
COVID-19: when should quarantine be enforced? 2864
Where do urologists stand in the era of novel coronavirus-2019 disease 2865
Where do we stand as dermatologists in combat with COVID -19 2866
Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events 2867
Why is SARS-CoV-2 infection milder among children? 2868
Will Tele dermatology be the silver lining during and after COVID -19 ? 2869
YouTube Corrects Its Misdiagnosis of Doc's Coronavirus Video 2870
Therapeutic strategies for critically ill patients with COVID-19 2871
Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction 2872
COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: “what the bleep do we know?” 2873
The role of environmental factors to transmission of SARS-CoV-2 (COVID-19) 2874
The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China 2875
A “One-Health” approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy 2876
Sonographic signs and patterns of COVID-19 pneumonia 2877
Recruitability and effect of PEEP in SARS-Cov-2-associated acute respiratory distress syndrome 2878
Lithium’s antiviral effects: a potential drug for CoViD-19 disease? 2879
Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta- analysis 2880
Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients? 2881
Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients? 2882
Selenium supplementation in the prevention of coronavirus infections (COVID-19) 2883
Emerging genetic diversity among clinical isolates of SARS-CoV-2: Lessons for today 2884
COVID-19: beta-thalassemia subjects immunised? 2885
Does zinc supplementation enhance the clinical efficacy of chloroquine/ hydroxychloroquine to win today's battle against COVID-19? 2886
Etoposide-based therapy for severe forms of COVID-19 2887
Estimating and projecting air passenger traffic during the COVID-19 coronavirus outbreak and its socio-economic impact 2888
Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation 2889
COVID-19 and pregnancy – where are we now? A review 2890
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract 2891
SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets – What to learn from Rheumatologists? 2892
SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in patients hospitalized with Coronavirus viral disease-2019 2893
Science Teacher Education in the Times of the COVID-19 Pandemic 2894
Screen time for children and adolescents during the COVID-19 pandemic 2895
Secondary Transmission of Coronavirus Disease from Presymptomatic Persons, China 2896
‘Self-collected upper respiratory tract swabs for COVID-19 test’: A feasible way to increase overall testing rate and conserve resources in South Africa 2897
Seroprevalence of SARS-CoV-2 among children visiting a hospital during the initial Seattle outbreak 2898
Sharing patient-level real-time COVID-19 data 2899
Simeprevir suppresses SARS-CoV-2 replication and synergizes with remdesivir 2900
South Asia is more vulnerable to COVID-19 pandemic 2901
Anakinra for severe forms of COVID-19: a cohort study 2902
Asthma and COVID-19: risks and management considerations 2903
Cancer and COVID-19: what dowe really know? 2904
Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study 2905
Coronavirus is the trigger, but the immune response is deadly 2906
COVID-19 human challenge studies: ethical issues 2907
Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients 2908
Lung function testing in the COVID-19 endemic 2909
Mitigating the risks of surgery during the COVID-19 pandemic 2910
Poor clinical outcomes for patients with cancer during the COVID-19 pandemic 2911
Rethinking cancer clinical trials for COVID-19 and beyond 2912
Safety fears overhyped drug hydroxychloroquine spark global confusion 2913
Shining a light on COVID-19 2914
Testing for COVID-19 2915
The right to health must guide responses to COVID-19
The role of nicotine in COVID-19 infection 2917
What explains the high rate of SARS-CoV-2 transmission in meat and poultry facilities? 2918
Laparoscopy in the coronavirus disease 2019 (COVID-19) era 2919
The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China 2920
Selenium supplementation in the prevention of coronavirus infections (COVID-19) 2921
Hypertension in the Time of the COVID-19 Pandemic: New Issues and Enduring Controversies 2922
A Framework for Biomarkers of COVID-19 Based on Coordination of Speech-Production Subsystems 2923
Acceptance and Adoption of Protective Measures During the COVID-19 Pandemic: The Role of Trust in Politics and Trust in Science 2924
ACE2 expression in human dorsal root ganglion sensory neurons: implications for SARS-CoV-2 virus- induced neurological effects 2925
Acute pulmonary embolism in COVID‑19 related hypercoagulability 2926
Acutely Altered Mental Status as the Main Clinical Presentation of Multiple Strokes in Critically Ill Patients With COVID-19. 2927
Addressing Public Health Emergencies via Facebook Surveys: Advantages, Challenges, and Practical Considerations 2928
An introduction to economic studies, health emergencies, and COVID-19 2929
Anakinra for severe forms of COVID-19: a cohort study 2930
Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19? 2931
Assessing concerns for the economic consequence of  the COVID-19 response and mental health  problems associated with economic vulnerability  and negative economic shock in Italy, Spain, and  the United Kingdom 2932
A ssociation between eating behavior and quarantine 2933
Association of Stay-at-Home OrdersWith COVID-19 Hospitalizations in 4 States 2934
Caring for the most vulnerable during the COVID-19 crisis 2935
Case series of acute arthritis during COVID-19 admission 2936
Response to: ‘Case series of acute arthritis in COVID-19 admission’ by López-González et al 2937
CD147 (BSG) but not ACE2 expression is detectable in vascular endothelial cells within single cell RNA sequencing datasets derived from multiple tissues in healthy individuals 2938
Challenges and solutions for maternity and gynecology services during the COVID-19 crisis in Jordan 2939
Changes of the patient management in dentistry during the pandemic caused by the SARS-Coronavirus 2—initial perspectives of a clinic of operative dentistry in Europe 2940
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry 2941
Children coronavirus dilemma 2942
Children with COVID-19 behaving milder may challenge the public policies: A Systematic Review and Meta-Analysis 2943
Clinical features of 1487 COVID‑19 patients with outpatient management in the Greater Paris: the COVID‑call study 2945
Clinical Questions and Answers on Gastrointestinal Endoscopy during the Novel COVID-19 Pandemic 2946
Primer Isothermal Amplification for SARS-CoV-2 Detection 2947
Covid 19 pandemic: Paranasal diagnostic imaging in patients with olfactory loss 2948
COVID-19: Changing Trendsand Its Impacton Future of Dentistry 2949
COVID-19: Social Distancing Flattened the Curve, Studies Show 2950
COVID-19 and a novel initiative to improve safety by 3D printing personal protective equipment parts from computed tomography 2951
COVID-19 and diabetes: Is there enough evidence? 2952
COVID-19 and parasitology 2953
COVID-19 and PM2.5 Sodium Chloride content 2954
Covid-19 and Sustainable Tourism:Macroeconomic Effect and Policy Comparison among Europe, the USA and China 2955
Covid-19: Doctors criticise Indian research agency for recommending hydroxychloroquine prophylaxis 2956
COVID-19 Heavy Metal Hypothesis 2957
COVID-19-related patient discrimination by healthcare workers:Asingle- center experience 2958
Critical adjustments in a department of orthopedics through the COVID-19 pandemic 2959
 Cytokine storm in COVID-19 and parthenolide: preclinical evidence 2960
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment 2961
Differentiating novel coronavirus pneumonia from general pneumonia based on machine learning 2962
Dose-dependent response to infection with SARS-CoV-2 in the ferret  model: evidence of protection to re-challenge 2963
Drug-utilisation Profiles and COVID-19 Retrospective Cohort Study in Italy 2964
Early COVID-19 infection after lung transplantation 2965
Early SNS-based monitoring system for the COVID-19 outbreak in Japan: a population-level observational study 2966
Electrical Storm in COVID-19 2967
Electrowetting‑on‑Dielectric System for COVID‑19 Testing 2968
Emergence of SARS-CoV-2 through recombination and strong purifying selection 2969
Ethical considerations for paediatrics during the COVID-19 pandemic: A discussion paper from the Australian Paediatric Clinical Ethics Collaboration 2970
Ethnicity and Covid-19: Standing on the shoulders of eugenics? 2971
Expansion of SARS-CoV-2-specific Antibody-secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients 2972
Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study 2973
From COVID-19 to the End of Neoliberalism 2974
Introductions and early spread of SARS-CoV-2 in the New York City area 2975
It is currently unknown whether SARS-CoV-2 is viable in semen or whether COVID-19 damages sperm 2976
Low serum level of apolipoprotein A1 is an indicator of severity in patients with coronavirus disease 2019 2977
Management of heart transplant candidates in the time of COVID-19 pandemic: looking for answers 2978
Managing teamwork in the face of pandemic: evidence-based tips 2979
Mathematical model of transmission dynamics with mitigation and health measures for SARS-CoV-2 infection in European countries 2980
Mathematical modeling of COVID-19 spreading with asymptomatic infected and interacting peoples 2981
Covid-19: Millions of women and children at risk as visits to essential services plummet 2982
MMWR summary: COVID-19 reports 2983
Modeling the Spread of COVID-19 Infection Using a Multilayer Perceptron 2984
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study 2985
New clues about role of pangolins in Covid-19 2986
Note From the Editor Clade X, Coronavirus, and the Challenges of Global Health Security 2987
Novel coronavirus pneumonia and acute pulmonary thromboembolism: casualty or causality? 2988
Offline: After COVID-19—is an “alternate society” possible? 2989
Practical approaches to pedagogically rich online tutorials in health professions education 2990
Practical recommendations for gynecologic surgery during the COVID-19 pandemic 2991
Preparing for the coming transnational cancer crisis amid the COVID‑19 pandemic 2992
Preparing Occupational Health Services for Pandemic: Lessons From the Bronx 2993
Prognostic Value of Neutrophil-To-Lymphocyte Ratio, Lactate Dehydrogenase, D-Dimer and CT Score in Patients with COVID-19 2994
Protecting American Lungs and Reversing Youth Tobacco Epidemic Act 2995
Provision of e-learning programmes to replace undergraduate medical students clinical general practice attachments during COVID-19 stand-down 2996
Right Ventricular Clot in Transit in COVID-19: Implications for the Pulmonary Embolism Response Team 2997
Risk for COVID-19 Resurgence Related to Duration and Effectiveness of Physical Distancing in Ontario, Canada 2998
Role of pulmonary circulation assessment in CT imaging in evaluating the severity and tendency of severe and critical COVID-19 pneumonia 2999
Safety and efficacy of amiodarone in a patient with COVID-19 3000
Security research on COVID-19 3001
Seventeen years of knowledge for teaching medical professionalism during the COVID-19 outbreak 3002
Severe immune thrombocytopenic purpura in critical COVID-19: a case report 3003
Shared Content on Facebook Often Propagates Inaccurate or Misleading Information Regarding Covid-19 3004
Shortlisting Phytochemicals Exhibiting Inhibitory Activity against Major Proteins of SARS-CoV-2 through Virtual Screening 3005
Silver Linings: An Opportunity to Improve Clinical Paradigms After the COVID-19 Pandemic 3006
Statistical analysis of the impact of environmental temperature on the exponential growth rate of cases infected by COVID-19 3007
Stroke as a an initial presentation of SARS-COV2 infection: a brief report 3008
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies 3009
Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India 3010
Systemic Inflammatory Cytokines Associate With SARS-COV-2 Viral Shedding Time in Covid-19 Inpatients 3011
Tele-ophthalmology amid COVID-19 pandemic—Hong Kong experience 3012
The antiviral and the coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - additional weapons in the fight against the COVID-19 pandemic? 3013
The apocalyptic virus that would make COVID-19 seem irrelevant: Leading scientist warns of the danger of a pandemic triggered by chicken farms that could kill half the world's population 3014
The impact of Covid-19 Movement Control Order on SMEs’ businesses and survival strategies 3015
The role of a Coronavirus disease 2019 pharmacist: an Australian perspective 3016
The role of palliative care in COVID-19
The Role of Transplant During a Pandemic The effect of the COVID-19 pandemic reveals the transplant community’s unique role—and value—within the healthcare field 3018
ung and Kidney Perfusion Deficits Diagnosed by Dual-Energy Computed Tomography in COVID–19 Patients 3019
Universal public use of surgical mask and respiratory viral infection 3020
Validation of a Mathematical Model Applied to Four Autonomous Communities in Spain to Determine the Number of People Infected by Covid-19 3021
Vascular Obliteration Due To Endothelial And Myointimal Growth In COVID-19 3022
Virtual melanoma checks during a pandemic 3023
Weak interactions of COVID-19 virus Mpro and peptide-like inhibitor N3: revealing the role of non-conventional hydrogen bonds by theoretical methods 3024
A case of Bacillus cereus bacteremia in a COVID-19 patient treated with steroids 3025
A Comprehensive Updated Review on SARS-CoV-2 and COVID-19 3026
Advocacy, Collaboration, and Intervention: A Model of Distance Special Education Support Services amidst COVID-19 3027
A More ExcellentWay: Recovering Mystery in COVID Care 3028
A Novel Cohorting and Isolation Strategy for Suspected COVID-19 Cases during a Pandemic 3029
A novel IDEA: The impact of serial interval on a modified-Incidence Decay and  Exponential Adjustment (m-IDEA) model for projections of daily COVID-19 cases 3030
A Python based Support Vector Regression Model for prediction of Covid19 cases in India 3031
A Review of Potential Antiviral Drugs and Vaccines to Treat COVID-19 3032
A Review on the Novel Coronavirus Disease based on In- silico Analysis of Various Drugs and Target Proteins 3033
Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort 3034
Addressing a National Crisis: The Spine Hospital and Department’s Response to the COVID-19 Pandemic in New York City 3035
African American children are at higher risk for COVID-19 infection 3036
A Little Autonomy Support Goes a Long Way: Daily Autonomy-Supportive Parenting, Child Well-Being, Parental Need Fulfillment, and Change in Child, Family, and Parent Adjustment Across the Adaptation to the COVID-19 Pandemic 3037
An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives 3038
An update on ACE2 amplification and its therapeutic potential 3039
Assessing the quality, readability and reliability of online information on COVID-19: an infoveillance observational study 3040
Behavioral Health and Response for COVID-19 3041
Breast Cancer Care During COVID-19 Pandemic 3042
Can indoor sports centers be allowed to re-open during the COVID-19 pandemic based on a certificate of equivalence? 3043
Caring for patients with diabetes during COVID-19 pandemic: Important considerations for pharmacists 3044
Characterization of accessory genes in coronavirus genomes 3045
Children’s heart and COVID-19: Up-to-date evidence in the form of a systematic review 3046
Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic . 3047
Clinical recommendations on lung cancer management during the COVID-19 pandemic 3048
TraumaManagement During and After COVID-19 3049
Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDITM enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma 3050
Contributions of dermatologists to COVID-19 research: a brief systematic review 3051
Control measures to prevent Coronavirus disease 2019 COVID-19 pandemic in endoscopy centers: a multi-centre study 3052
Coronavirus disease-2019 in pregnancy with neurological manifestations versus pregnancy with eclampsia: Need for liberal testing to rule out the masquerades 3053
Could Autism Spectrum Disorders be a Risk Factor for COVID-19? 3054
COVID-19 and Diabetes: Could Diabetes Technology Research Help Pave the Way for Remote Health care? 3055
COVID-19 Pandemic: Exacerbating Racial/Ethnic Disparities in Long-Term Services and Supports 3056
COVID-19: Persistence, Precautions, Diagnosis and Challenges 3057
COVID-19 and the immune system 3058
COVID-19 Evolution and Alternative Medicine- A Review 3059
COVID-19: Gene Transfer to the Rescue? 3060
Covid-19 in Bone Marrow Transplant Recipients: Reflecting on a Single Centre Experience 3061
COVID-19 target: A specific target for novel coronavirus detection 3062
COVID19, the pandemic which may exemplify a need for harm-reduction approaches to eating disorders: a reflection from a person living with an eating disorder 3063
COVID-19—A Novel Zoonotic Disease: A Review of the Disease, the Virus, and Public Health Measures 3065
Critical Review of the Literature on Chest CT and Coronavirus Disease (COVID-19): Data Adjustment 3066
Developing a risk assessment score for cancer patients during COVID-19 pandemic. 3067
Diagnostic performances and thresholds: the key to harmonization in serologi- cal SARS-CoV-2 assays? 3068
Different Cases of SARS-CoV-2 Infection and Its Impact on Health and Economy with Special Emphasis on Antiviral Drug Targets 3069
Docking study of Chloroquine and Hydroxychloroquine interaction with SARS-CoV-2 spike glycoprotein-An in silico insight into the comparative efficacy of repurposing antiviral drugs 3070
Emergency Radiology During the COVID-19 Pandemic: The Canadian Association of Radiologists Recommendations for Practice 3071
Emotional distress and associated sociodemographic risk factors during the COVID-19 outbreak in Spain 3072
Establishing early warning systems by monitoring Covid-19 (SARS-CoV-2) in wastewater Covid-19 (SARS-CoV-2)’un Atıksularda İzlenmesi ile Erken Uyarı Sistemlerinin Oluşturulması 3073
Estimation of the Serial Interval and Basic Reproduction Number of COVID-19 in Qom, Iran, and Three Other Countries: A Data-Driven Analysis in the Early Phase of the Outbreak 3074
Evaluating the potential of different inhibitors on RNA-dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2: A molecular modeling approach 3075
Evaluation of potential therapeutic options for COVID-19 3076
Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: a potential role of cellular FURIN in the pathogenesis of SARS-CoV-2 3077
Facing SARS-CoV-2 outbreak in immunotherapy era 3078
Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by  international and European Associations on Priority Procedures During the COVID-19 Pandemic 3079
Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study 3080
 Genomic analysis of early SARS-CoV-2 strains introduced in Mexico 3081
Guidelines for Balancing Priorities in Structural Heart Disease During the COVID-19 Pandemic 3082
Head-to-head comparison of four antigen-based rapid detection tests for the diagnosis of SARS-CoV-2 in respiratory samples 3083
Hybrid Coordination for Coping with the Medical Surge from the COVID- 19 Pandemic: Paired-Assistance Programs in China 3084
Immune Status of COVID-19 patients with reference to SARS and MERS 3085
Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: experiences of a general hospital 3086
Increasing resilience by creating an adaptive salesforce 3087
Initial data from an experiment to implement a safe procedure to perform PA erect chest radiographs for COVID-19 patients with a mobile radiographic system in a “clean” zone of the hospital ward 3088
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19 3089
COVID-19, SARS and Bats Coronaviruses Genomes Unexpected Exogenous RNA Sequences 3090
Knowledge of Latin American gastroenterologists and endoscopists regarding SARS-CoV-2 infection Conocimiento sobre la infección por SARS-CoV-2 de Gastroenterólogos y Endoscopistas de Latino América 3091
Popular Reactions To External Threats in Federations 3092
Licking the lungs, biting the brain: malignant MCA infarct in a patient with COVID 19 infection 3093
Long-term surveillance of bat coronaviruses in Korea: Diversity and distribution pattern Running Title: Long-term surveillance of Korea bat coronaviruses 3094
Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia 3095
Managing burns during COVID-19 outbreak. 3096
Mathematical modeling of COVID-19 fatality trends: Death kinetics law versus infection-to-death delay rule 3097
Measuring COVID-19 and Influenza in the Real World via Person-Generated Health Data 3098
Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients 3099
Meeting the Transitional Care Needs of Older Adults with COVID-19 3100
Molecular Characterization and Amino Acid Homology of Nucleocapsid (N) Protein in SARS-CoV-1, SARS-CoV-2, MERS- CoV, and Bat Coronavirus 3101
N-Acetylcysteine: a potential therapeutic agent for SARS-CoV-2 3102
Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019 A Review 3104
Neuropsychiatric aspects of COVID-19 Pandemic: A Selective Review 3105
Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19 3106
Non-operative management of acute appendicitis in a pediatric patient with concomitant COVID- 19 infection 3107
Institutional Collective Action During Covid-19: Lessons in local economic development. 3108
Pandemicity, COVID-19 and the limits of public health ‘science’ 3109
Pathological Findings in the Testes of COVID-19 Patients: Clinical Implications 3110
Paying Participants in COVID-19 Trials 3111
Pediatric endoscopic procedures during the COVID‑19 pandemic: an Italian center experience 3112
Pentoxifylline: An Immunomodulatory Drug for the Treatment of COVID-19 3113
Perforated acute abdomen in a patient with COVID-19: an atypical manifestation of the disease 3114
Perioperative Outcomes of Urological Surgery in Patients with SARS-CoV-2 Infection 3115
 Pharmacokinetics of Favipiravir in Critically Ill Patients with COVID-19 3116
Physicochemical properties of SARS-CoV-2 for drug targeting, virus inactivation and attenuation, vaccine formulation and quality control 3117
Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2 3118
Profile and quality of published reviews on COVID-19. 3119
Proteome Organization of COVID-19: Illustrating Targets for Vaccine Development 3120
Relative Limited Impact of COVID-19 on Diabetes: A Personal View 3121
Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states 3122
Reply: Vitamin C as a Possible Therapy for COVID-19 3123
Restarting after COVID-19: A Data-driven Evaluation of Opening Scenarios 3124
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic 3125
Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks 3126
SARS-CoV-2 perturbs  the Renin-Angiotensin System and energy metabolism 3127
Service delivery during the COVID-19 Pandemic: Experience from the Oxford Bone Tumour and Soft Tissue Sarcoma Unit 3128
Strengthening of Molecular Diagnosis of SARS-CoV-2 / COVID-19 with a Special Focus on India 3129
Taste and Smell Dysfunction in COVID-19 Patients 3130
Telehealth for Musculoskeletal Physiotherapy 3131
Testing for SARS-CoV-2: the day the world turned its attention to the clinical laboratory 3132
The COVID-19 Pandemic and Physical Activity 3133
The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway 3134
The future of cancer research after COVID-19 pandemic: recession? 3135
The gendered impact of coronavirus disease (COVID-19): do estrogens play a role? 3136
The Interventional Radiology Service During the COVID-19 Pandemic: Steps forManaging the Risk of Infection 3137
The Post-Corona World and International Political Landscape: Emerging Challenges 3138
The Serendipitous Impact of COVID-19 Pandemic A Rare Opportunity for Research and Practic 3139
The Spectrum of Cardiac Manifestations in Coronavirus Disease 2019 (COVID-19) – a Systematic Echocardiographic Study 3140
The Use of Information Technology for Managing the COVID-19 Pandemic: Practice in China 3141
Thinking Too Much About the Novel Coronavirus. The Link Between Persistent Thinking About COVID-19, SARS-CoV-2 Anxiety and Trauma Effects 3142
TraumaManagement During and After COVID-19 3143
Treatment of COVID-19 with pentoxifylline : Could it be a potential adjuvant therapy? 3144
Unravelling the Myths of R0 in Controlling the Dynamics of COVID-19 Outbreak: a Modelling Perspective 3145
Virtual Court Policy For Criminal Justice on Corona Virus Disease Pandemic 3146
Virtualization of science education: a lesson from the COVID‑19 pandemic 3147
Whole-process emergency training of personal protective equipment (PPE) helps health care workers against COVID-19: design and effect 3149
Comparative assessment ofmultiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings 3150
A brief-review of the risk factors for covid-19 severity 3151
A positive perspective during COVID-19 related to groundwater crisis 3152
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 3153
 ACE inhibitors protective Against server covid-19? 3155
Active case finding with case management: the key to tackling the COVID-19 pandemic 3156
Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil 3157
Advanced renal cell carcinoma and COVID-19 — a personal perspective 3158
Aerosol generation from high speed ophthalmic instrumentation and the risk of contamination from SARS COVID 19 3159
An andrologist in the front line Covid-19 team 3160
An integrated national scale SARS-CoV-2 genomic surveillance network 3161
Analysis of Reported Case Fatality Rate and Characteristics of COVID-19 Patients in Italy 3162
Analyzing hCov genome sequences: Applying Machine Intelligence and beyond 3163
Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign” 3164
Antimicrobial use, drug-resistant infections and COVID-19 3165
Are adversities and worries during the COVID-19 pandemic related to sleep quality? Longitudinal  analyses of 45,000 UK adults 3166
Are adversities and worries during the COVID-19 pandemic related to sleep quality? Longitudinal analyses of 45,000 UK adults 3167
Are Cryptocurrencies a Safe Haven for Equity Markets? An International Perspective from the COVID-19 Pandemic 3168
ARIMA forecasting of COVID-19 incidence in Italy, Russia, and the USA 3169
Assembly of an integrated human lung cell atlas reveals that SARS-CoV-2 receptor is co-expressed with key elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells 3170
Assessing resilience of healthcare infrastructure exposed to COVID‑19: emerging risks, resilience indicators, interdependencies and international standards 3171
Association of Noninvasive Oxygenation Strategies With All-Cause Mortality in Adults With Acute  hypoxemic Respiratory Failure A Systematic Review and Meta-analysis 3172
Author Correction: COVID-19: the vasculature unleashed 3173
Bald men at higher risk of severe case of Covid-19, research finds 3174
Bathing facilities and health phronesis: a preliminary English investigation 3175
Blood clots and TAM receptor signalling in COVID-19 pathogenesis 3176
Building an international consortium for tracking coronavirus health status 3177
Canakinumab in a subgroup of patients with COVID-19 3178
Cancer Care in “Covid” Times—Indian Solutions to Universal Problems 3179
Challenge Trials—Could Deliberate Coronavirus Exposure Hasten Vaccine Development? 3180
Chest CT features of coronavirus disease 2019 (COVID‑19) pneumonia: key points for radiologists 3181
Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence 3182
Circulating endothelial cells in COVID-19
Claims of aWeaker COVID-19 Virus Disputed 3184
Clinical Potential of UTE-MRI for Assessing COVID-19: Patient- and Lesion-Based Comparative Analysis 3185
Colorectal cancer surgery during the COVID-19 pandemic 3186
Comparative assessment ofmultiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings 3187
Consensus Virtual Screening of Dark Chemical Matter and Food Chemicals Uncover Potential Inhibitors of SARS-CoV-2 Main Protease 3188
Continuing our work: transplant surgery and surgical oncology in a tertiary referral COVID‑19 center 3189
Coronavirus Disease 2019: Clinical Review Doença de Coronavírus 2019: Revisão Clínica 3190
Coronavirus pandemic (COVID-19) - Clinical trials advice 3191
Correlation Between N95 Extended Use and Reuse and Fit Failure in an Emergency Department 3192
COVID-19: providing support for men with prostate cancer 3193
COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy 3194
COVID-19 and acute pulmonary embolism: what should be considered to indicate a computed tomography pulmonary angiography scan? 3195
COVID-19 and essential pregnant worker policies 3196
COVID-19 and heme oxygenase: novel insight into the disease and potential therapies 3197
COVID-19 and Hypercoagulable State: A New Therapeutic Perspective 3198
COVID-19 and the eye: how much do we really know? A best evidence review 3199
Covid-19 and the pandemic of fear: reflections on mental health 3200
COVID-19: challenges for a new epoch 3202
COVID-19 has no effect on gravity 3203
COVID-19 mortality rates in the European Union, Switzerland, and the Ueffect of timeliness, lockdown rigidity, and population density 3204
COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid 3205
COVID-19 vaccine development pipeline gears up 3206
COVID-19 vaccines: neutralizing antibodies and the alum advantage 3207
Covid-19: Validity of key studies in doubt after leading journals issue expressions of concern 3208
Creatingvaccines appropriate for Asian infectiousdisease strains 3209
Critical evaluation of online information 3210
CT features of pneumonia during COVID-19 pandemic warrant caution: An illustrative case report of cholangiocarcinoma with Pneumocystis jiroveci pneumonia 3211
Effects of Dynamic Organization and Digital Innovation on the Hotel Tourism Industry during the Coronavirus Pandemic Period 3212
Delay discounting of compliance with containment measures during the COVID-19 outbreak: a survey of the Italian population 3213
Demographic Stability on Mechanical Turk Despite COVID-19 3214
Dermatological insights from Google Trends: what does the public think is important during COVID-19 lockdown? 3215
Detection of SARS-CoV-2 in Different Specimens of Inpatients, Covert Infectors and Discharged Persons 3216
Diabetes and covid-19: more than the sum of two morbidities 3217
Discovery of a potent angiotensin converting enzyme 2 inhibitor from Chinese Medicinal and Edible Plant via Docking-based Virtual Screening 3218
DNA may make people with Type A blood who catch coronavirus 50% more likely to need oxygen or ventilator support, study suggests 3219
Does the newly observed inflammatory syndrome in children demonstrate a link between uncontrolled neutrophil extracellular traps formation and COVID-19? 3220
Multi-parametric disease dynamics study and analysis of the COVID-19 epidemic and implementation of population-wide intrusions: The Indian perspective 3221
Does Vitamin D play a role in the management of Covid-19 in Brazil? 3222
Domestic violence in the COVID-19 pandemic: a forensic psychiatric perspective 3223
Systems One_ An Introduction to Systems Thinking-Future Systems (1980) 3224
Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany 3225
Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study 3226
Emergence of novel coronavirus and progress toward treatment and vaccine 3227
Eosinophilic granulomatosis with polyangiitis mimicking COVID-19: a case report. 3228
Epidemiology of the 2020 Pandemic of COVID‑19 in the State of Texas: The First Month of Community Spread 3229
Eurosurveillance _ SARS-CoV-2-related p.. 3230
Even covid-19 can’t kill the anti-vaccination movement 3231
Expanding Role and Reach: A Community-Centered ChildWelfare Response to COVID-19 3232
Exposure to cough aerosols and development of pulmonary COVID-19
Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis 3234
Expression of Concern: Mehra MR et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 3235
Gender differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders among 1,942 non-hospitalized patients with COVID-19 3236
Genetic polymorphisms mediating behavioural and immune response to pathogens may moderate the impact of the COVID-19 pandemic: a pilot study 3237
Global mental health and COVID-19 3238
Global outbreak research: harmony not hegemony 3239
Governments andWHO changed Covid-19 policy based on suspect data from tiny US company 3240
Gut mycobiota alterations in patients with COVID-19 and H1N1 and associations with immune and gastrointestinal symptoms 3241
Hepatology in the time of COVID-19
Here come the anti-Covid antibodies 3243
How ExerciseMay Affect The Immune System Against COVID-19? Egzersiz COVID-19'a Karşı Bağışıklık Sistemini Nasıl Etkileyebilir? 3245
Immuno-protective effect of BCG Vaccine in COVID-19 Patients in Tuberculosis Endemic Countries 3246
Implementation of An Online COVID-19 Epidemic Calculator for Tracking the Spread of  the Coronavirus in Singapore and Other Countries 3247
The Grass Is Always Greener, or Is It? 3248
Increasing Host Cellular Receptor—Angiotensin- Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV (or SARS-CoV-2) Infection 3249
Influe nce o f d iab e tes me ll itus o n the se ve r ity a nd fa ta lity o f SARS-CoV-2 infec t io n 3250
Influenza and COVID-19 Co-infection: Report of 6 cases and review of the Literature 3251
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19 3252
Initiation of the Global Coalition for Radiotherapy during the COVID-19 pandemic 3253
Interpreting COVID Findings avoid These Dangerous Mistakes 3254
It is not the time for science fiction
‘It opens up awhole new universe’:Revolutionary microscopy technique sees individual atoms for first time 3256
Leading a COVID-19 cohort ward without blades: a surgeon’s perspectives 3257
Leading the Fight Against the Pandemic: Does Gender ‘Really’ Matter?
Learning from the past: did experience with previous epidemics help mitigate the impact of COVID‑19 among spine surgeons worldwide? 3259
Making Decisions in a COVID-19World 3260
Male mortality and the German response: lessons from COVID-19 3261
Malignant Cerebral Ischemic Stroke Associated with COVID-19 Infection 3262
Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review 3263
Medical Abortion Care During a Pandemic 3264
Mental health among otolaryngology resident and attending physicians during the COVID-19 pandemic: National study 3265
Mission command: applying principles of military leadership to the SARS- CoV-2 (COVID-19) crisis: more than just ‘mission command’ 3266
MMArt-ACM’20: International JointWorkshop on Multimedia Artworks Analysis and Attractiveness Computing in Multimedia 2020 3267
Modeling mitigation of influenza epidemics by baloxavir 3268
Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature 3269
Multiple epidemic wave model of the Covid-19 pandemic 3270
Computational approach for the design of potential spike protein binding natural compounds in SARS- CoV2 3271
Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients 3272
Ensuring and Sustaining a Pandemic Workforce 3273
Of Heroes and Cowards
The Legal Authority for States’ Stay-at-Home Orders 3275
New Focus on Renin-Angiotensin System Role 3276
Novel indicator of change in COVID-19 spread status 3277
Of Viruses, Vaccines, and Variability: Qualitative Meaning Matters 3278
Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID‑19: sex differences and  recovery time in real‑life 3279
On mothering and being mothered: a personal reflection on women’s productivity during Covid-19 3280
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. 3281
Over the Rainbow: Navigating the COVID-19 Pandemic While Living With PTSD 3282
Pandemic Risk and Diversification 3283
Pandemics and the neurological manifestations of viral respiratory illnesses including Covid-19. 3284
Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid 3285
Persistence of PCR (RT-PCR) Positivity in COVID-19 Recovered Patients: A Call for Revised Hospital Discharge Criteria 3286
Phylogenetic supertree reveals detailed evolution of SARS-CoV-2 3287
Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19 3288
Population serology for SARS-CoV-2 is essential to regional and global preparedness 3289
Population serology for SARS-CoV-2 is essential to regional and global preparedness 3290
Predictors of engaging in voluntarywork during the Covid-19 pandemic: analyses of data from 31,890 adults in the UK 3291
Pre-Procedural Surveillance Testing for SARS-CoV-2 in an Asymptomatic Population in the Seattle Region Shows Low Rates of Positivity 3292
Proposals for Copyright Law and Education During the Covid-19 Pandemic Emily Hudson∗ and Paul Wragg 3293
Quantifying additional COVID-19 symptoms will save lives 3294
Recurrence of SARS-CoV-2 RNA in upper respiratory tract samples from recovered patient with coronavirus disease 2019 (COVID-19) 3295
Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing 3296
Regulatory Consideration on Preparation and Clinical Use of COVID-19 Convalescent Plasma 3297
Research and urology at a time of COVID-19 3298
Respiratory protection for health care workers: A 2020 COVID‐19 perspective 3299
Retroauricular dermatitis with vehement use of ear loop face masks during COVID19 pandemic 3301
Revenge of the Experts: Will COVID-19 Renew or Diminish Public Trust in Science? 3302
Risk Factors and Outcomes of Acute Kidney Injury in Critically Ill Patients With Coronavirus Disease 2019 3303
Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis 3304
Sarbecovirus comparative genomics elucidates gene content of SARS-CoV-2 and functional impact of COVID-19 pandemic mutations 3305
SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts 3306
SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020 3307
Says who? The significance of sampling in mental health surveys during COVID-19 3308
Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study 3309
Stem Cell Research Responds to COVID-19: Deepak Srivastava, Fiona Watt, and George Daley 3310
Supply Chain Disruption Due to Covid_19 3311
Swab Tests and COVID-19 – Italy case studied using Artificial Intelligence, Statistical Analysis and MLR 3312
Swapping drills for dressings: redeployment of dentists to community nursing 3313
Talking to children about illness and death of a loved one during the COVID-19 pandemic 3314
Corona and the Consequences Ten Propositions on the Future of Digital Business Models for Industry 4.0 in the Post-Corona Economy 3315
The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties. 3316
COVID-19 pandemic: Emerging perspectives and future trends 3317
The COVID-19 pandemic 3318
The fascinating history of clinical trials 3319
The impact of COVID-19 pandemic in the colorectal cancer prevention 3320
The issue of recurrently positive patients who recovered from COVID-19 according to the current discharge criteria: investigation of patients from multiple medical institutions in Wuhan, China. 3321
The need for privacy with public digital contact tracing during the COVID-19 pandemic 3322
The Neurobiology of Social Distance 3323
The Penumbra Indigenous populations: left behind in the COVID-19 response 3324
The Role of Social Trust in Citizen Mobility During COVID-19 3325
The trauma and acute care surgeon in the COVID-19 pandemic era O cirurgião de trauma e emergência na era da pandemia de COVID-19 3326
Transient acute-onset tetraparesis in a COVID-19 patient 3327
Treating Severe COVID-19 in Cancer Patients 3328
Unlocking UK COVID-19 policy 3329
The curious case of the SF doctor who’s been coronavirus-positive nearly 90 days and counting 3330
A COVID-19 vaccine has passed its first human trial.But is it the frontrunner? 3331
Viral load and secondary transmission in COVID-19
Vitamin D    Low-Hanging Fruit in COVID-19 3333
WHO advises public to wear face masks when unable to distance 3334
Why do we die? Uncovering the genetic connections causing COVID-19 disease severity 3335
A comparative study on the time to achieve negative nucleic acid testing and hospital stays between Danoprevir and Lopinavir/Ritonavir in the treatment of patients with COVID-19 3336
A modified deep convolutional neural network for detecting COVID-19 and pneumonia from chest X-ray images based on the concatenation of Xception and ResNet50V2 3337
A multi-group SEIRA model for the spread of COVID-19 among heterogeneous populations 3338
A protocol for acute stroke unit care during the COVID-19 pandemic 3339
Acute intestinal ischemia in a patient with COVID‑19 3340
Acute myocardial injury in patients hospitalized with COVID-19 infection: A review 3341
Admissions to Veterans Affairs Hospitals for Emergency Conditions During the COVID-19 Pandemic 3342
Adverse effects of COVID-19 related lockdown on pain, physical activity and psychological wellbeing in people with chronic pain 3343
Airway management of angioedema patients during the COVID-19 pandemic 3344
An Online Clinical Exam for Fellowship Certification during COVID-19 Pandemic 3345
Analysis of a SARS-CoV-2 infected individual reveals development of potent neutralizing antibodies to distinct epitopes with limited somatic mutation 3346
Analysis of Spatial Spread Relationships of Coronavirus (COVID-19) Pandemic in the World using Self Organizing Maps 3347
Ancillary considerations for endodontic emergency treatment of Covid-19 positive patients 3348
Anemia and iron metabolism in COVID-19: A systematic review and meta-analysis 3349
Antihypertensive drugs in COVID-19 infection 3350
Are Patients Dying 'From' COVID or 'With' COVID? 3351
Aspects of nano-enabling biosensing systems for intelligent healthcare; towards COVID-19 management 3352
Association of asthma and its genetic predisposition with the risk of severe COVID-19 3353
Barriers in Social Distancing during Covid19 pandemic - Is a message for forced lockdown? 3354
Breakthrough close on coronavirus antibody therapy: reports 3355
Can Hypericum perforatum (SJW) prevent cytokine storm in COVID-19 patients? 3356
Commentary: Cardiac surgery during the COVID-19 pandemic: Feeling our way in the dark 3357
Cardiovascular medications and regulation of Covid-19 receptors expression 3358
CardiovascularManifestations of Covid-19: A Review 3359
Caring forWomen Who Are Planning a Pregnancy, Pregnant, or Postpartum During the COVID-19 Pandemic 3360
Chloroquine dosage regimens in patients with COVID-19: Safety risks and optimization using simulations 3361
Class I HLA allele restricted antigenic coverage for Spike and N proteins is associated with divergent outcomes for COVID-19 3362
Comparative analysis of laboratory indexes of severe and non-severe patients ,infected with COVID-19 3363
Compliance measurement and observed influencing factors of hand hygiene based on COVID-19 guidelines in China 3364
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality 3365
Controls of SARS-CoV-2 transmission in orthodontic practice 3366
Coronavirus Disease (COVID-19): Spread, Awareness and Strategic Containment 3367
COVID-19: Healthy environmental impact for public safety and menaces oil market 3368
COVID-19 and the healthcare workers Lessons from the Bhagavad Gita (the ‘Lord’s Song’) from India during these difficult times 3369
COVID-19 as a Confounding Factor in a Child Submitted to Staged Surgical Palliation of Hypoplastic Left Heart Syndrome: One of the First Reports of SARS-CoV-2 Infection in Congenital Heart Disease Patients 3370
COVID-19 created chaos across the globe: Three novel quarantine epidemic models 3371
COVID-19 created chaos across the globe: Three novel quarantine epidemic models 3372
COVID-19 in health care workers – A systematic review and meta-analysis 3373
COVID-19 risk factors among health workers: A rapid review 3374
COVID-19 spreading in Rio de Janeiro, Brazil: Do the policies of social isolation really work? 3375
COVID-19 Therapeutics Outcome: Systematic Review and Data Analysis 3376
Covid‐19 trajectories – Monitoring pandemic in the worldwide context 3377
COVID-19 vaccine development pipeline gears up 3378
COVID-19, Health, Conservation, and Shared Wellbeing: Details Matter 3379
COVID-19, Interferons, and Depression: A Commentary 3380
COVID-19–Associated Collapsing Focal Segmental Glomerulosclerosis: A Report of 2 Cases 3381
Deciphering the TCR repertoire to solve the COVID-19 mystery 3382
Decisions in HCT and wine-making 3383
Detection dogs as a help in the detection of COVID-19 Can the dog alert on COVID-19 positive persons by sniffing axillary sweat samples ? Proof-of-concept study 3384
Developing an ultra-efficient microsatellite discoverer to find structural differences between SARS-CoV-1 and Covid-19 3385
Selective C-reactive protein (CRP) apheresis for Covid-19 patients suffering from organ damage 3386
Routine antiemetic prophylaxis with dexamethasone during COVID-19: Should oncologists reconsider? 3387
Sample sizes for surveillance of S. aureus transmission to monitor effectiveness and provide feedback on intraoperative infection control including for COVID-19 3388
SARS-CoV-2 infection serology: a useful tool to overcome lockdown? 3389
Search for therapeutics against COVID 19 targeting SARS-CoV-2 papain-like protease: an in silico study 3390
Short-term forecasting COVID-19 cumulative confirmed cases: Perspectives for Brazil 3391
Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019 3392
Special Ambulatory Gynecologic Considerations in the Era of COVID-19 and Implications for Future Practice 3393
Stress and burnout in health care workers during COVID-19 pandemic: validation of a questionnaire 3394
Syndemic frameworks to understand the effects of COVID-19 on commercial driver stress, health, and safety 3395
Temporal Dynamics of COVID‑19 Outbreak and Future Projections: A Data‑Driven Approach 3396
The Deadly Corona Virus (Covid-19) 3397
The effect of sex hormone on COVID-19: analysis of laboratory-con 3398
The global effects of Covid-19-induced uncertainty 3399
The impact of COVID-19 on medical education: our students perception on the practice of long distance learning 3400
Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. 3401
Reducing Social Isolation of Seniors during COVID-19 through Medical Student Telephone Contact 3402
Recommendations to Manage Patients for Bariatric Surgery in the COVID-19 Pandemic: Experience from China 3403
Recommendations for management of diabetic foot ulcers during COVID-19 outbreak 3404
Rapid generation of neutralizing antibody responses in COVID-19 patients 3405
Quantifying the role of social distancing, personal protection and case detection in mitigating COVID-19 outbreak in Ontario, Canada 3406
Putting the Public Back in Public Health — Surveying Symptoms of Covid-19 3407
Protective roles of flu infections and BCG vaccination in lowering Covid-19 mortality 3408
Kitchen Range Oven Enabled One-tube RT-LAMP for RNA Detection at Home - A Potential Solution for Large-scale Screening of COVID-19 3409
Potential pathophysiological mechanisms leading to increased COVID-19 susceptibility and severity in obesity 3410
Population vulnerability to COVID-19 in Europe: a burden of disease analysis 3411
Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: from direct patient care to telemedicine 3412
Perceived Impact of Urologic Surgery Training Program Modifications due to COVID-19 in the United States 3413
Pediatric COVID-19: Systematic review of the literature 3414
Outcomes of hydroxychloroquine usage in United States veterans hospitalized with COVID-19 3415
On the clinical psychologist's role in the time of COVID-19, with particular reference to experience ained in pediatric oncology 3416
Ocular manifestations of coronavirus disease 2019 3417
Not Only Virus Spread: The Diffusion of Ageism during the Outbreak of COVID-19 3418
Neurological involvement in SARS-CoV-2 infection: a clinical systematic review. 3419
Multifocal laminar cortical brain lesions: a consistent MRI finding in neuro‑COVID‑19 patients 3420
More about chloroquine and hydroxychloroquine 3421
Molecular chronicles of cytokine burst in COVID-19 patients with cardiovascular diseases 3422
Modelling the spread of COVID-19 with new fractal-fractional operators: Can the lockdown save mankind before vaccination? 3423
Many paths to COVID-19 lymphocyte dysfunction 3424
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective 3425
Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China 3426
Lung ventilation function characteristics of survivors from severe COVID-19: a prospective study 3427
Long‑term intubation and high rate of tracheostomy in COVID‑19 patients might determine an unprecedented increase of airway stenoses: a call to action from the European Laryngological Society 3428
Lessons from being challenged by COVID-19 3429
Is Hesperidin Essential for Prophylaxis and Treatment of COVID-19 Infection? 3430
Informatics is a critical strategy in combating the COVID-19 pandemic 3431
Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences 3432
Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review 3433
Impaired glucose metabolism in patients with diabetes, prediabetes and obesity is associated with severe Covid-19 3435
Development of Pediatric Surgical Decision-Making Guidelines for COVID-19 in a New York City Children's Hospital 3436
Diabetes and COVID-19 related mortality in the critical care setting: A real-time national cohort study in England 3437
Perspective Down Syndrome and COVID-19: A Perfect Storm? 3438
Doxycycline as a Potential Partner of COVID-19 Therapies 3439
Systems One_ An Introduction to Systems Thinking-Future Systems (1980) 3440
Forecasting the prevalence of COVID-19 outbreak in Egypt using nonlinear autoregressive artificial neural networks 3441
Gastric Occlusion due to the Intragastric Balloon Displacement in the Era of Coronavirus Disease-19 (COVID-19) Pandemic, Operative Management: a Case Report 3442
Generalized Z-numbers with hesitant fuzzy linguistic information and its application to medicine  election for the patients with mild symptoms of the COVID-19 3443
Harnessing the Immune System to Overcome Cytokine Storm and Reduce Vi ra l  Load in COVID- 19:AReview of the Phases of Illness and Therapeutic Agents 3444
High Performance Simulations to Support Real-time COVID19 Response 3445
How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection? 3446
How to Rapidly Determine First-in-Children Dosing for COVID-19 Therapeutics 3447
Hyperacute multi‑organ thromboembolic storm in COVID‑19: a case report 3448
Identification of critical airports for controlling global infectious disease outbreaks: Stress-tests focusing in Europe 3449
Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole genome sequencing 3450
Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-term Population-Scale Immunity 3451
IL-15 immunotherapy is a viable strategy for COVID-19 3452
Imaging Profile of the COVID-19 Infection A Narrative Overview 3453
The impact of COVID-19 pandemic upon stability and sequential irregularity of equity and cryptocurrency markets 3454
The impact of occupational risk from COVID on GP supply in England: A cross- sectional study 3455
The Importance of Long-term Care Populations in Models of COVID-19 3456
Themystery of “missing” visits in an emergency cardiology department, in the era of COVID‑19.; a  time‑series analysis in a tertiary Greek General Hospital 3457
The Social Cost of Contacts: Theory and Evidence for the COVID-19 Pandemic in Germany 3458
Commentary: COVID-19: “There is no Education like Adversity” 3460
Thrombosis in COVID-19: clinical outcomes, biochemical and pathological changes, and treatments 3461
Tracheostomy intervention in intubated COVID positive patients: A survey of current clinical practice  among ENT surgeons 3462
Understanding the impact of the COVID-19 pandemic on well-being and virtual care for people living with dementia and care partners living in the community 3463
Use of Tracheostomy During the COVID-19 Pandemic: CHEST/AABIP/AIPPD: Expert Panel Report 3464
Vehicle related injury patterns during the COVID-19 pandemic: What has changed? 3465
Vitamin K found in some cheeses could help fight Covid-19, study suggests 3466
Waiting for Certainty on Covid-19 Antibody Tests — At What Cost? 3467
What orthopedic surgeons need to know about Covid-19 pandemic
When Going Digital Becomes a Necessity: Ensuring Older Adults’ Needs for Information, Services, and Social Inclusion During COVID-19 3469
Which are the “emergent” dermatologic practices during COVID-19 pandemic? Report from the  lockdown in Milan, Italy 3470
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019 3471
Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series 3472
Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature 3473
A single-cell atlas of the peripheral immune response in patients with severe COVID-19 3474
A study on clinical effect of Arbidol combined with adjuvant therapy on COVID-19 3475
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel 3476
An effective protocol for heart transplantation during COVID-19 outbreak 3477
Change in practice in gynecologic oncology during the COVID-19 pandemic: a social media survey 3478
China’s diplomacy and changing the COVID-19 narrative 3479
Clinical characteristics and outcomes of COVID-19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital inWuhan, China 3480
Clinical characteristics, outcomes and follow-up of COVID-19 infection in cancer patients 3481
Clinical Features and Lymphocyte Subsets in Recovered Covid-19 Patients With Prolonged Viral Rna Shedding Duration 3482
Coronavirus lockdowns may have prevented at least 3MILLION deaths in Europe and almost 500,000 in the UK, study suggests 3483
COVID-19 and physical geography – yellow card 3484
COVID-19 Health Technology Governance, Epistemic Competence, and the Future of Knowledge in an Uncertain World 3485
COVID-19 presenting with diarrhea and hyponatraemia 3486
COVID-19 Scientific Facts Vs. Conspiracy Theories 0 – 1  sience Fails to Convince Even Highly Educated Individuals 3487
Covid-19: the renin–angiotensin system imbalance hypothesis 3488
COVID‑19—does social distancing include species distancing? 3489
Dangerous Kawasaki-like condition seen in children with COVID-19 is a NEW disease - and it may be caused by coronavirus, new study suggests 3490
How Does Coronavirus Spread? 3491
Early Insights into Immune Responses during COVID-19 3492
Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review 3493
Elderly nursing homes residents—are they a priority in national COVID-19 strategies? 3494
Environmental Maintenance with Effective and Useful Zoning for Severe COVID-19 due to Protect to and from Patients and Medical Staffs 3495
Epidemiological approximation of the enteric manifestation and possible fecal-oral transmission in COVID-19: A preliminary systematic review 3496
Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests 3497
Estimatingthe effects of non-pharmaceutical interventionson COVID-19 inEurope 3498
Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from  surgery due to the COVID-19 pandemic 3499
Finding a way forward in the community 3500
Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism 3501
Health and sustainability in post-pandemic economic policies 3502
High temperature slows coronavirus disease 2019 transmission rate: A within and among country analysis 3503
Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study 3504
Identification of unique mutations in SARS-CoV-2 strains isolated from India suggests its attenuated pathotype 3505
Ignoring scientific advice during the Covid-19 pandemic: Bolsonaro’s actions and discourse 3506
Low-Intensity Monitoring After Stroke Thrombolysis During the COVID-19 Pandemic 3507
Management of common elective paediatric orthopaedic conditions during the COVID-19 pandemic: the Montreal experience 3508
Management of gestational diabetes during ‘COVID19 time’ 3509
Migrant workers and COVID-19 3510
Minimising airborne infection risk 3511
Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak 3512
NAFLD — sounding the alarm on a silent epidemic 3513
Need for ensuring care for neuro-emergencies—lessons learned from the COVID-19 pandemic 3514
Occult SARS-CoV-2 Infection; A Possible Hypothesis For Viral Relapse 3515
Peritoneal dialysis for COVID-19-associated acute kidney injury 3516
Perspectives on the relationship of renal disease and coronavirus disease 2019 3517
Pharmacists step up to the challenge of COVID-19 3518
Point of view: Should COVID-19 patients be supplemented with vitamin D? 3519
Political Actors Participation within Nation-Wide Social Distancing during CoVID-19 Pandemic in Twitter 3520
Prediction of SARS-CoV-2 Main Protease Inhibitors from Several Medicinal Plant Compounds by Drug Repurposing and Molecular Docking Approach. 3521
Presenting Characteristics, Comorbidities, and Outcomes Among Hospitalized Patients with 2019 Novel Coronavirus-infected Pneumonia in Tehran, Iran 3522
Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection 3523
Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies 3524
Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience 3525
Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression 3526
Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma 3527
The COVID-19 pandemic in Singapore: what does it mean for arthroplasty? 3528
The effect of large-scale anti-contagion policiesontheCOVID-19pandemic 3529
The inhibition of IL-2/IL-2R gives rise to CD8+ Tcell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia 3530
The potential impact of COVID-19-related disruption on tuberculosis burden 3531
Tuberculosis in the time of COVID-19: quality of life and digital innovation 3532
Twelve Tips for Transitioning Your Didactic Curriculum to the Online Platform in the Current COVID-19 Era and Beyond 3533
Uncovering the underlying mechanisms of Compound Yuxingcao Mixture in the treatment of COVID-19 based on network pharmacology 3534
What is the role of supplementation with ascorbic acid, zinc, vitamin D, orN-acetylcysteine for prevention or treatment of COVID-19? 3535
Will COVID 19 Turn Higher Education into Another Mode? 3536
23andMe finds evidence that blood type plays a role in COVID-19 3537
A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies 3538
A valuable and affordable handheld
ultrasound in combating COVID-19
ACE2 and COVID-19 and the resulting ARDS 3540
Activation of TRL-7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic:
Imiquimod as a Potential Therapy
Acute hemorrhage after intra-cerebral biopsy in COVID-19 patients: a report of 3 cases 3542
Acute kidney injury in critically ill patients with COVID‑19 3543
Acute multi-vessel coronary occlusion revealing COVID-19 in a young adult 3544
Addressing the public mental health challenge of COVID-19 3545
Adult congenital heart disease and the COVID-19 pandemic 3546
Alcohol consumption in the coviD-19 era 3547
Anaesthetic Considerations for Rationalizing Drug Use
in the Operating Theatre: Strategies in a Singapore Hospital During COVID-19
Application of in-silico reverse vaccinology for designing multi-epitope vaccine against Coronavirus 3549
Are treat-to-target and dose tapering strategies for
rheumatoid arthritis possible during the COVID-19 pandemic?
Association of COVID-19 pandemic withmeteorological
parameters over Singapore
Bat-borne virus diversity, spillover and emergence 3552
Covid-19: Better data on outbreaks will help control infection, say experts 3553
Between Fear and Courage: Attitudes, Beliefs, and and Waiting List Candidates during the COVID-19 PandemicBehavior of Liver Transplantation Recipients 3554
Can a disease be conquered by extensive publications, guidelines and interminable meetings?reading 3555
Caring for Health Professionals in the COVID-19 Pandemic Emergency: Toward an “Epidemic of Empathy” in Healthcare 3556
Caring for the carers: Advice for dealing with sleep problems of hospital staff during the COVID-19 outbreak 3557
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2 3558
Clinical significance of the correlation between changes in the major intestinal bacteria species and COVID-19 severity 3559
Comparison of Hospitalized Patients with pneumonia caused by COVID-19 and influenza A in children under 5 years 3560
Competition law in times of crisis—tackling the COVID-19 challenge 3561
Considerations for Development and Use of AI in Response to COVID-19 3562
Considerations for Development and Use of AI in Response to COVID-19-1 3563
Considering how biological sex impacts immune responses and COVID-19 outcomes 3564
Coronavirus Disease 2019 (COVID‐19) in autoimmune hepatitisa lesson from immunosuppressed patients 3566
Coronavirus Disease 2019 (Covid-19) presenting as purulent fulminant myopericarditis and cardiac tamponade 3567
Coronavirus disease 2019 outbreak 3568
Could Interferon Drugs Help Fight COVID-19_ - WebMD 3570
Could sudden sensorineural hearing loss be the sole manifestation of COVID-19  An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss 3571
COVID-19 and Cushing’s syndrome_ recommendations for a __special population with endogenous glucocorticoid excess 3572
COVID-19 and endoscopy training 3573
COVID-19 and Kidney Disease  Molecular Determinants and Clinical Implications in Renal Cancer 3574
COVID‐19 and telemedicine in hemophilia in a patient with severe hemophilia A and orthopedic surgery 3575
COVID-19 and the Futures of Machine Learning 3576
COVID-19 diagnostics—not at the expense of other diseases 3577
COVID-19 in a Patient with Liver Cirrhosis 3578
COVID‐19 in recent kidney transplant recipients 3579
COVID-19 pandemic and the reduction in ST-elevation myocardial infarction admissions 3580
Covid-19 Therapeutic Prospects Cardiotoxicity Concerns 3581
Detection of SARS-CoV-2 by bronchoscopy after negative nasopharyngeal testing Stay vigilant for COVID-19 3582
Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2 3583
Diagnosing COVID-19-associated pulmonary aspergillosis 3584
Diagnostic utility of additional whole-chest CT as part of an acute abdominal pain CT imaging pathway during the COVID-19 pandemic 3585
Disappearing ac COVID-19 and paediatric emergency department attendances 3586
Distributions of time, place, and population of novel coronavirus disease 2019 (COVID-19) from January 20 to February 10, 2020, in China 3587
Early experience with convalescent plasma as immunotherapy for COVID‐19 in China  Knowns and unknowns 3588
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 3589
Editorial  Nutrition and COVID-19 3590
Effectiveness of WhatsApp for blood donor mobilization campaigns during COVID‐19 pandemic 3591
Effects of COVID-19 on Business and Research 3592
Effects of home quarantine for COVID-19 community control in Shenzhen, China, 2020 3593
Effects of the COVID-19 lockdown on human sleep and rest-activity rhythms 3594
emperature, Humidity, and Latitude Analysis to Estimate Potential Spread__and Seasonality of Coronavirus Disease 2019 (COVID-19) 3595
Environmental temperature does not correlate with COVID-19 spreading and death toll 3596
Faecal immunohistochemical testing in the COVID-19 era  balancing risk and costs 3597
Family Therapy and COVID‐19 International Reflections during the Pandemic from Systemic Therapists across the Globe 3598
Fight against novel coronavirus A perspective of medicinal chemists 3599
Frailty and mortality in hospitalized older adults with COVID-19  retrospective observational study 3600
Gastrointestinal, and hepatic involvement in Severe Acute  Corona Virus 2 (SARS-CoV-2) infection: A reviewRespiratory Syndrome 3601
Generation of a Broadly Useful Model for COVID-19 Pathogenesis Vaccination, and Treatment 3602
Genomic search for COVID-19 severity clues 3603
Global Covid-19 Case Fatality Rates 3604
Half of pregnant women in UK hospitals are from ethnic minorities 3605
Hematological features of persons with COVID-19 3606
Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling 3607
High rates of 30-day mortality in patients with cirrhosis and COVID-19 3608
Holding CoVID in check through JAK The MPN-approved compound ruxolitinib as a potential strategy to treat SARS-CoV-2 induced systemic hyperinflammation 3609
Hospital beds and personal protective equipment planning for COVID-19 pandemic A computer simulation approach 3610
How Fear Appeal Approaches in COVID-19 Health Communication May Be Harming the Global Community 3611
Hydroxychloroquine side-effects raise concerns for rheumatology patients 3612
Ibuprofen use and clinical outcomes in COVID-19 patients 3613
Immunological environment shifts during pregnancy may affect the risk of developing severe complications in COVID‐19 patients 3614
Impact of Digital Surge during Covid-19 Pandemic 3615
Impact of the COVID-19 crisis on imaging in oncological trials 3616
Independent Correlates of Hospitalization in 2040 Patients with COVID-19 at a Large Hospital System in Michigan, United States 3617
Infographic. Cooling strategies to attenuate PPE-induced heat strain during the COVID-19 pandemic 3618
Kawasaki disease in a COVID-19-struck region 3619
Keeping governments accountable the COVID-19 Assessment Scorecard (COVID-SCORE) 3620
Keeping governments accountable the COVID-19 Assessment Scorecard (COVID-SCORE) 3621
Lack of evidence for systemic cytomegalovirus reactivation in maintenance hemodialysis patients _ SpringerLink 3622
Linking key intervention timings to rapid decline of the COVID-19 effective reproductive number to quantify lessons from mainland China 3623
Loss of Smell and Taste  Potential of Using Them as Markers for Early Detection 3624
Low rate of bacterial co-infection in patients with COVID-19 3625
Management of patients with acute leukemia during the COVID-19 outbreak  practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation 3626
Managing fragility fractures during the COVID-19 pandemic 3627
Marketplaces as Public Spaces in Times of The Covid‐19 Coronavirus Outbreak 3628
Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2 3629
Monitoring investments in coronavirus research and development 3630
Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak 3631
Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system__ 3632
New Strategy for COVID-19 An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection 3633
Olfactory and taste disorders in COVID-19  a systematic review 3634
On the evolutionary epidemiology of SARS-CoV-2 3635
Optimising SARS-CoV-2 pooled testing for low-resource settings 3636
Oral mucosal lesions in a COVID-19 patient  new signs or secondary manifestations 3637
Overview of lethal human coronaviruses 3638
Oxford COVID-19 Evidence Service__ 3639
Pathologists in pursuit of the COVID-19 culprit 3640
Patient flow in the largest French psychiatric emergency centre in the context of the COVID-19 pandemic 3641
Persistence of SARS-CoV-2 in the environment and COVID-19 transmission risk from environmental matrices and surfaces 3642
Physician Supply During the Coronavirus Disease 2019 (COVID-19) Crisis 3643
Povidone-iodine demonstrates rapid in-vitro virucidal activity against SARS-CoV-2, the virus causing COVID-19 disease 3644
Preparing Primary Care for COVID-20 3645
Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection 3646
Prognostic Value of Serum Creatinine in Severe Covid-19 Patients in Wuhan, China 3647
Psychological Distress among Iranian Health-Care Providers Exposed to Coronavirus Disease 2019 (COVID-19) 3648
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy  a two-centre descriptive study 3649
Pulse Oximetry for Monitoring Patients with COVID-19 at Home  Potential Pitfalls and Practical Guidance 3650
Relational ethical approaches to the COVID-19 pandemic 3651
Risks to children during the covid-19 pandemic  some essential epidemiology 3652
SARS-Cov2 Clinical Diagnostics  Academic Scientists Take on the COVID-19 Pandemic 3653
SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs ARBs 3654
SEIR model for COVID-19 dynamics incorporating the environment and social distancing 3655
Severity and risk of COVID ‐19 in cancer patients  An evidence based learning 3656
Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019 3657
Simple barrier device to minimize facial exposure of endoscopists during COVID‐19 pandemic 3658
Sleep in University Students Prior to and During COVID-19 Stay-at-Home Orders 3659
Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic 3660
Stress Induced Cardiomyopathy Precipitated by COVID-19 and Influenza A Co-Infection 3661
Study on the dynamic change law and correlation between CT imaging manifestations and cellular immunity of 2019 novel coronavirus disease 3662
Surgical Mask–the Saviour from its Invention to the COVID-19 Era 3663
Technology in the COVID-19 era  pushing the boundaries 3664
Ten recommendations for supporting open pathogen genomic analysis in public health 3665
The 2020 coronavirus lockdown and seismic monitoring of anthropic activities in Northern Italy 3666
The Covid danger zone_ Coronavirus IS seasonal, say scientists who created vibrant maps that can help predict when and where the virus will spread 3667
The Ethical Governance of the Digital During and After the COVID-19 Pandemic 3668
The First Posttruth Pandemic 3669
The future of critical care lessons from the COVID-19 crisis 3670
The Janus kinase 1 2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation 3671
The legal extension of the role of pharmacists in light of the COVID-19 global pandemic – A review 3672
The natural history and transmission potential of asymptomatic __SARS-CoV-2 infection 3673
Transcatheter management of severe aortic stenosis during the COVID-19 pandemic 3674
Transmission and Control Efforts of COVID-19 3675
Treating asthma in the COVID-19 pandemic 3676
Untitled 2 62 3677
Urgent Peritoneal Dialysis in Patients With COVID-19 and Acute Kidney Injury  A Single-Center Experience in a Time of Crisis in the United States 3678
Vaccination strategies to combat novel corona virus SARS-CoV-2 3679
Vitamin D affects Covid-19 mortality 3680
Vox Sanguinis International Forum on Hospital Transfusion Services’ Response to COVID‐19 3681
We risk letting a new threat expose us to old enemies 3682
What’s in a name  Simula ion and technology enhanced learning uses and opportunities in the era of COVID-19 3683
Where are the women  Gender inequalities in COVID-19 research authorship 3684
Who's to blame  These three scientists are at the heart of the Surgisphere COVID-19 scandal 3685
[67Ga] Ga-citrate and COVID-19-associated pneumonia 3686
A COVID-19 Level Overreaction Is Needed for Substance Use Disorder Treatment  The Future Is Mobile 3687
A hypothesis about the role of fetal hemoglobin in COVID-19 3688
A minimal common outcome measure set for COVID-19 clinical research 3689
A Molecularly Imprinted Polymer-Based Technology for Rapid Testing of COVID-19 3690
A plea for avoiding systematic intubation in severely hypoxemic patients with COVID-19-associated respiratory failure 3691
Absence of Evidence of Transmission of Coronavirus Disease 2019 from a Young Child to Mother Despite Prolonged Contact 3692
Acute cor pulmonale from saddle pulmonary embolism in a patient with previous Covid-19 – should we prolong prophylactic anticoagulation 3693
Acute increase in deaths among adult congenital heart disease patients during COVID-19 - single center experience 3694
Aerosols May Be at the Core of COVID-19 Transmission 3695
An Investigation of the Effect of COVID-19 on OCD in Youth in the Context of Emotional Reactivity, Experiential Avoidance, Depression and Anxiety 3696
Are scientists about to reverse their support for ‘good’ cholesterol_ For years we were told it reduces the risk of a heart attack, but new research may be about to change that advice 3697
Asymptomatic SARS-CoV-2 infection 3698
Best practice recommendations for point-of-care lung ultrasound in patients with 3699
Binding Mechanism and Structural Insights into the Identified Protein Target of Covid-19 with In-Vitro Effective Drug Ivermectin 3700
Bradycardia in Patients With COVID-19 A Calm Before the Storm 3701
Challenges in Neonatal COVID-19 Infection 3702
Chilblains in children in the time of Covid‐19 3703
Clinical Characteristics of COVID‐19 in patients with pre‐existing ILD 3704
Clinical Features of Hypertensive Patients With Covid-19 Compared With a Normotensive Group 3705
Clinical Features of Patients with Probable 2019 Novel Coronavirus Infected Pneumonia in Rasht, Iran 3706
Clinical Review Point-of-Care Ultrasound in the Evaluation of COVID-19 3707
Colon Cancer and SARS-CoV-2  Impact of ACE2 Expression in Susceptibility to COVID-19 3708
Corona virus (Covid-19) – ITS implications in pediatric orthopedic care 3709
COVID ‐19 and the heart  An update for clinicians 3710
COVID-19  nuclecular diagnostics overview 3711
COVID-19 and “Lockdown” in Organ transplantation in the UK 3712
COVID-19 and ethnicity  who will research results apply to 3713
COVID-19 diagnostic approaches different roads to the same destination 3714
COVID-19 in patients with thoracic malignancies (TERAVOLT) first results of an international, registry-based, cohort study 3715
Covid-19 pneumonia, Takotsubo syndrome and left ventricle thrombi 3716
COVID-19 presenting as neutropenic fever 3717
COVID-19, nuclear war, and global warming lessons for our vulnerable world 3718
Cytokine storm and leukocyte changes in mild versus severe SARS‐CoV‐2 infection Review of 3939 COVID‐19 patients in China and emerging pathogenesis and therapy concepts 3719
Digital tablets to improve quality of life of COVID-19 older inpatients during lockdown 3720
Effectiveness of Autonomous Learning Materials for Students during the COVID-19 Pandemic 3721
Endemic and Emerging Coronavirus Pulmonary Infections 3722
Epidemiological Trends, Characteristics, and Distribution of COVID-19 3723
Family‐based treatment via videoconference  Clinical recommendations for treatment providers during COVID ‐19 and beyond 3724
Feasibility of enhanced recovery after surgery program in colorectal surgery during COVID-19 pandemic in Italy should we change something 3725
Gendered effects of school closures during the COVID-19 pandemic 3726
Genotyping SARS-CoV-2 through an interactive web application 3727
Growth, detection, quantification, and inactivation of SARS-CoV-2_compressed 3728
Guidance for the Procurement of COVID‐19 Convalescent Plasma  Differences between High and Low‐Middle Income Countries 3729
Guidance on Diagnosis, Prevention and Treatment of Thromboembolic 3730
Higher Mortality and Infection Rate in a Region or Country Suggest a Longer Time of COVID-19 Disease Pandemic 3731
Identification of miRNA-mRNA Interaction in Vero Cells after Infection of SADS-CoV through Integrative Transcriptome Analysis 3732
Impact of COVID-19 on academic activities and way forward in Indian Optometry 3733
Incidental COVID‐19 in a Heart‐Kidney Transplant Recipient with Malnutrition and Recurrent Infections  Implications for the SARS‐CoV‐2 Immune Response 3734
Infection prevention and control in nursing severe coronavirus disease (COVID-19) patients during the pandemic 3735
Inhibition of Anti-viral Stress Granule Formation by infectious bronchitis virus endoribonuclease nsp15 Ensures Efficient Virus Replication 3736
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies  Structural genomics approach 3737
Is Hypertension a Real Risk Factor for Poor Prognosis in the COVID-19 Pandemic 3738
Is this the mutation that made coronavirus spread like wildfire in NYC and Italy_ Super-infectious strain has four-times as many 'spikes' that let it invade human cells compared to milder forms seen in California  3739
Large‐scale National Screening for COVID‐19 in China 3740
Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients 3741
Major cluster of pediatric “ true ” primary chilblains during the COVID‐19 pandemic 3742
Management strategies adopted by a pediatric palliative care network in northern Italy during the COVID‐19 pandemic 3743
Mind the App—Considerations on the Ethical Risks of COVID-19 Apps 3744
Movement control as an effective measure against Covid-19 spread in Malaysia 3745
Natural History of Asymptomatic SARS-CoV-2 Infection 3746
Neuropathological Features of Covid-19 3747
Neuropathological Features of Covid-19 3748
Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection 3749
Persistent viral RNA shedding after COVID ‐19 symptom resolution in older convalescent plasma donors 3750
Physiological advantages of children against COVID‐19 3751
Possible therapeutic agents for COVID 19 a comprehensive review 3752
Prognostic value of Cardiac Biomarkers in COVID-19 Infection 3753
Prognostic value of Cardiac Biomarkers in COVID-19 Infection 3754
Receptor utilization of angiotensin converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV 3755
Recommendations for Cardiopulmonary Resuscitation (CPR) of patients with suspected or confirmed COVID-19 3756
Recommendations for surgical management of recurrent nasopharyngeal carcinoma during COVID ‐19 pandemic 3757
Report of EEG Finding on Critically Ill Patients with COVID ‐19 3758
Repurposing cefuroxime for treatment of COVID 19 a scoping review of in silico studies 3759
Response of Practicing Chiropractors during the Early Phase of the COVID-19 Pandemic 3760
Risk Perception and Behavioral Responses Related to COVID-19 Among the Iranian General Population An Application of the Extended Parallel Process Model 3761
Salivary detection of SARS‐CoV ‐2 (COVID ‐19) and implications for oral health‐care providers 3762
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship 3763
ShahrestanStates_1399_03_22 3764
Sleepless in COVID-19 3765
Studying the pathophysiology of coronavirus disease 2019 3766
Subcorneal Pustular Dermatosis with Temporary Autoimmune Features during COVID-19 Pandemic 3767
Subtotal laparoscopic cholecystectomy for gangrenous gallbladder during recovery from COVID-19 pneumonia 3768
Successful management of the first reported case in Austria of COVID-19 with ARDS 3769
Temporal clinical and laboratory response to interleukin-6 receptor blockade with Tocilizumab in 89 hospitalized patients with COVID-19 pneumonia 3770
Ten challenging questions about SARS CoV 2 and COVID 19 3771
Test which can diagnose coronavirus in just 30 minutes by analysing urine, blood or saliva samples is developed by scientists  3772
The ‘new normal’ in mental healthcare 3773
The Covid‐19 ‘infodemic’ a new front for information professionals 3774
The COVID-19 pandemic and health inequalities 3775
The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity 3776
The effects of physical distancing on population mobility during the COVID-19 pandemic in the UK 3777
The great pause a minor theory exploration of COVID 19 response in Switzerland 3778
The MediShout App  Communication, Control and Capturing Staff Voice During Covid-19 3779
The red half moon nail sign a novel manifestation of Coronavirus infection 3780
The role of extracellular vesicles in COVID-19 virus infection 3781
The Society of Behavioral Sleep Medicine SBSM COVID 19 Task Force Objectives and Summary Recommendations for Managing Sleep during a Pandemic 3782
Transmission of COVID-19 virus by droplets and aerosols A critical review on the unresolved dichotomy 3783
Understanding COVID-19 - A Molecular Perspective 3784
Unexpected finding of myocardial depression in 2 healthy young patients with COVID‐19 pneumonia  possible support for COVID‐19‐related myocarditis 3785
Update on mechanisms of transmission of severe acute respiratory syndrome Coronavirus (SARS-COV-2) in endoscopy 3786
What COVID-19 has taught us 3787
Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early prognostic marker for severe COVID-19 3788
Network-Enhanced Emotional Profiling in the Time of COVID-19 3789
2019 novel coronavirus (COVID‑19) pneumonia complications: the importance of lung ultrasound 3790
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2
 A compendium answering 150 questions on COVID-19 and SARS-CoV-2 3792
A Clinical Decision Support System for the Treatment of COVID-19 with Multi-Criteria Decision-Making Techniques 3793
A COVID-19 case report from asymptomatic contact: implication for contact isolation and incubation management 3794
A cross-sectional community-based observational study of asymptomatic SARS-CoV-2 prevalence in the greater Indianapolis area 3795
A Framework for Managing the COVID-19 Infodemic: Methods and Results of an Online, Crowdsourced WHO Technical Consultation 3796
Cremation based estimates suggest significant under- and delayed reporting of COVID-19  epidemic data in Wuhan and China 3797
Critical medical ecology and SARS-COV-2 in the urban environment: a pragmatic, dynamic approach to explaining and planning for research and practice 3798
Crowdsourcing drug discovery for pandemics
CT Fluid-Blood Levels in COVID-19 Intracranial Hemorrhage 3800
Cytokine biomarkers of COVID-19 3801
Delivering evidence-based critical care for mechanically ventilated patients with COVID-19 3802
Dementia care and COVID-19 pandemic: a necessary digital revolution 3803
Dermatological findings in SARS-CoV-2 positive patients: An observational study from North India 3804
Development and validation of a knowledge-driven risk calculator for critical illness in COVID-19 patients 3805
Diagnosis of coronavirus infection-19 3806
Doing nothing does something: Embodiment and data in the COVID-19 pandemic 3807
Double COVID-19 Confirmed Case Fatality Rate in Countries with High Elderly Female Vitamin D eficiency Prevalence 3808
Drinking alone:COVID-19, lockdown, and alcohol-related harm 3809
Drug Repurposing for Covid-19: Discovery of Potential Small-Molecule Inhibitors of Spike Protein-ACE2 Receptor Interaction Through Virtual Screening and Consensus Scoring 3810
Dysregulation of the immune response affects the outcome of critical COVID-19 patients 3811
20-9 East Asia Decouples from the United States: TradeWar, COVID-19, and East Asia’s New Trade Blocs 3812
Economic impact of government actions to control COVID-19 pandemic: Evidence from financial markets 3813
Effect of a bundle of intervention strategies for the control of COVID-19 in Henan, a neighboring  rovince ofWuhan, China 3814
Effect of immunomodulatory action of iodine and natural supplements in preventing COVID-19 acquisition and preventing COVID related complications 3815
Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19 3816
Effects of the COVID-19 pandemic on the mental health of prisoners 3817
Eight Weeks Later—The Unprecedented Rise of 3D Printing during the COVID-19 Pandemic—A Case Study, Lessons Learned, and Implications on the Future of Global Decentralized Manufacturing 3818
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? 3819
Equitable Care for Critically Ill Patients from Culturally Diverse Communities in the COVID-19 Pandemic 3820
Erratum: Global Access to Handwashing: Implications for COVID-19 Control in Low-Income Countries 3821
Erythropoietin as candidate for supportive treatment of severe COVID-19 3822
Evaluation of Health Status of Children with Autoinflammatory Diseases During COVID-19 Pandemic 3823
Evidence collection guide for medicinal products to prevent or treat COVID-19 3824
Evidence standards framework for SARS-CoV-2 and anti-SARS-CoV-2 antibody diagnostic tests 3825
Expression of Concern: Mehra MR et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. 3826
Extensions and Adaptations of Existing Medical Information System in Order to Reduce Social Contacts During COVID-19 Pandemic 3827
Factors affecting the number of Covid-19 cases and the death rate: Empirical Evidence from German States 3828
Fatal Covid-19 in a Malnourished Child with Megaloblastic Anemia 3829
Fears, feelings and findings about COVID-19 disease in hospitalized cancer patients in a tertiary Hospital in Spain. 3830
Field-deployable, rapid diagnostic testing of saliva samples for SARS-CoV-2. 3831
Forecasting the Spread of COVID-19 under Different Reopening Strategies 3832
Four in 10 Patients With Coronavirus Infection Shed Virus in Stool 3833
Further to the left. Stress-induced increase of spatial pseudoneglect during the COVID-19 lockdown 3834
Genetic Analysis Tracks SARS-CoV-2 Mutations in Human Hosts 3835
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 3836
Glass fragment injury to the craniocervical junction with inter-atlanto-occipital penetration to the subarachnoid space: Not-to-be-missed important aspects of craniocervical trauma even in the middle of the COVID-19 pandemic: a case report with a review o 3837
Global governance for COVID-19 vaccines 3838
Global research trend in the treatment of the new Coronavirus diseases (COVID-19) : bibliometric analysis. 3839
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study 3840
GM-CSF in the treatment of COVID-19: a new conductor in the pathogenesis of cytokine storm? 3841
Green endoscopy: a call for sustainability in the midst of COVID-19 3842
Guideline for diagnosis and treatment of spine trauma in the epidemic of COVID-19 3843
Has Covid-19 burned itself out? Around the world, more patients seem to be surviving the infection, writes JOHN NAISH 3844
Head and neck oncological ablation and reconstruction in the COVID-19 era – Our experience to date 3845
Health Care Equity and Covid-19: Assessing the Relative Effectiveness of Egalitarian Governance and Health System Capacity on the Covid-19 Pandemic 3846
High-Flow Nasal Cannula therapy: A Feasible Treatment in Vulnerable Older COVID-19 Patients on the Wards 3847
Home testing for COVID-19: lessons from direct to consumer genetics 3848
Host range of SARS-CoV-2 and implications for public health 3849
Household studies provide key insights on the transmission of, and susceptibility to, SARS-CoV-2 3850
How— andWhen— Can the Coronavirus Vaccine Become a Reality? 3851
How a global social lockdown helps to unlock time for sleep 3852
Howdeadly is thecoronavirus?Scientistsareclose toananswer 3853
How doctors’ fears of getting COVID-19 can mean losing the healing power of touch: One physician’s  story 3854
How Effective Are Social Distancing Policies? Evidence on the Fight Against COVID-19 from Germany 3855
How to build the plane while flying: VTE/PE Thromboprophylaxis Clinical Guidelines for COVID-19 Patients 3856
Human Challenge Trial (HCT) for COVID-19 Vaccine Development; How possible is it? 3857
Hydroxychloroquine use in COVID-19: what is the basis for baseline tests? 3858
IBD in the time of corona — vigilance for immune-mediated diseases 3859
Immune status coulddetermineefficacyofCOVID-19 therapies 3860
Immune-related Factors Associated with Pneumonia in 127 Children with Coronavirus Disease 2019 inWuhan 3861
Impact of Governmental interventions on epidemic progression and workplace activity during the COVID-19 outbreak 3862
Impact of the COVID-19 virus outbreak on movement and play behaviours of Canadian children and youth: A national survey 3863
In silico analysis of SARS-CoV-2 spike glycoprotein and insights into antibody binding 3864
Indications and Findings on Transthoracic Echocardiogram in COVID-19 3865
Individual biosafety barrier in dentistry: an alternative in times of covid-19. Preliminary study 3866
Infection risk assessment of COVID-19 through aerosol transmission: a case study of South China Seafood Market 3867
Informing the public health response to COVID-19 (and lessons learnt for future pandemics): a systematic review of risk factors for disease, severity, and mortality 3868
Integrated COVID-19 convalescent plasma treatment and antibody research program at a single  academic medical center 3869
International COVID-19 Penetration Determinants: An Exploratory Analysis of Cultural, Economic, Political, Health and Environmental Factors Across 96 Countries 3870
Internet Use, Risk Awareness, and Demographic Characteristics Associated with Engagement in Preventive Behaviors and Testing: A Cross-sectional Survey on COVID-19 in the U.S. 3871
Invited response to editorial “COVID-19 wash your hands but don’t erase them from our profession – considerations on manual therapy past and present” 3872
Is COVID-19 An Indiscriminate Tsunami? Bank Immunity and Variation in Government Policy Responses 3873
Is COVID-19 Risk Linked to Blood Type? 3874
Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome  coronavirus 2 3875
Lack of susceptibility of poultry to SARS-CoV-2 andMERS-CoV 3876
Large vessel stroke and COVID-19: Case report and literature review 3877
Living repository of millions of T and B cell receptor sequences from patients with COVID-19 3878
Longitudinal immune profiling reveals distinct features of COVID-19 pathogenesis 3879
Low and high infection dose transmissions of SARS-CoV-2 in the first COVID-19 clusters in Northern Germany 3880
Lung Function Decline and Other Physiological Changes in Health Workers after Working in COVID- 19 Isolation Wards: An Observational Study 3881
Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS‐CoV‐2 in golden Syrian hamsters 3882
Matt Morgan: Covid-19 and the need for bold decisions 3883
Men’s health: COVID-19 pandemic highlights need for overdue policy action 3884
Mental health of health-care workers in the COVID-19 era 3885
Modeling SARS-CoV-2 infection in mice 3886
Modeling the Spring 2020 New York City COVID-19 Epidemic: New Criteria and Methods for Prediction 3887
Modulation*of*COVID119*Epidemiology*by*UV1B*and*–A*Photons*from*the*Sun* 3888
Molecular Docking suggests repurposing of Brincidofovir as a potential drug targeting SARS- CoV-2 "COVID-19" ACE2 receptor and main protease 3889
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling 3890
Multidisciplinary research priorities for the COVID-19 pandemic 3891
Multidisciplinary research priorities for the COVID-19 pandemic 3892
Myocardial Injury at Early Stage and Its Association with Death Risk of Patients with COVID-19: A Hospital-Based Prospective Case-Cohort Study 3893
Narrative Reflections on Masculinity and Fatherhood during Covid-19 Confinement in Spain 3894
Negative SARS-CoV-2 PCR in patients with chilblain-like lesions 3895
Network pharmacology based investigation into the bioactive ingredients and molecularmechanisms of QingFeiPaiDu Decoction treating COVID-19 3896
New international guidance on quality, safety and efficacy of DNA vaccines 3897
Covid-19: WHO raises concerns about new cases in Beijing 3898
Novel rapid identification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by real-time RT-PCR using BD Max Open System in Taiwan 3899
Offline: A novel solution to live with coronavirus 3900
Older Adults and the Economic Impact of the COVID-19 Pandemic 3901
Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID‑19): a review of current evidence 3902
OM Forum—COVID-19 Scratch Models to Support LocalDecisions 3903
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study 3904
Oral drug repositioning candidates and synergistic remdesivir combinations for the prophylaxis and treatment of COVID-19 3905
Overview of therapeutic drug research for COVID-19 in China 3906
Pediatric COVID‑19: what disease is this? 3907
Performance Assessment of SARS-CoV-2 PCR Assays Developed by WHO Referral Laboratories 3908
Perspective: COVID-19 Outbreak and Information Tools 3909
Pharmacy degree apprenticeships put on hold by COVID-19 3910
Physical activity during COVID-19 quarantine 3911
Placental pathology in COVID-19
Pooling and Balking: Decisions on COVID-19 Testing 3913
Potential role for nitazoxanide in treating SARS-CoV-2 infection 3914
Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors (nAChR) and beyond 3915
Predicting mammalian hosts in which novel coronaviruses can be generated 3916
Incidence and clinical profiles of COVID-19 in patients with gynecological surgery- A single center descriptive study from Spain. 3917
Incidental Lowering of Otitis-media Complaints in Otitis-prone Children During COVID-19 Pandemic: Not All Evil Comes to Hurt 3918
Prevalence and Predictors of General Psychiatric Disorders and Loneliness during COVID-19 in the United Kingdom: Results from the Understanding Society UKHLS 3919
Prioritising children’s rights in the COVID-19 response 3920
Prognosis of frail hospitalized COVID-19 patient: Better than expected? 3921
Prognosis of patients with sickle cell disease and COVID-19: a French experience 3922
Prognostic Symptoms on COVID-19 Severity 3923
Protocol for Reducing COVID-19 Transmission Risk in EEG Research 3924
Psoriasis and risk of the COVID-19 infection: Is there a role for Angiotensin Converting Enzyme (ACE)? 3925
Publishing in the time of COVID-19 3926
Pulmonary embolism in acute medicine: a case-based review incorporating latest guidelines in the COVID-19 era 3927
Recognising and addressing the impact of COVID-19 on obsessive-compulsive disorder 3928
Regional BCG vaccination policy in former East- and West Germany may impact on both severity of  SARS-CoV-2 and incidence of childhood leukemia 3929
Regulatory and safety considerations in deploying a locally fabricated, reusable, face shield in a hospital responding to the COVID-19 pandemic 3930
Religion as a Health Promoter During the 2019/2020 COVID Outbreak: View from Detroit 3931
Renal dysfunction in hospitalised children with COVID-19 3932
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 3933
Repositioning of 8565 Existing Drugs for COVID-19 3934
Repurposing minocycline for COVID-19 management: mechanisms, opportunities and challenges 3935
Research in brief COVID-19 in patients with IBD 3936
Responses to the COVID-19 crisis in Russia, Ukraine, and Belarus 3937
Risk and severity of COVID-19 and ABO blood group in transcatheter aortic valve patients 3938
Risk Factors for the Critical Illness in SARS-CoV-2 Infection: a Multicenter Retrospective Cohort Study 3939
Role of neutrophil-lymphocyte-ratio in the mortality of males diagnosed with COVID-19 3940
Rose and in-vitro inhibition of Sars-CoV-2 spike: ACE-2 interaction 3941
Safe surgical tracheostomy during the COVID-19 pandemic: A protocol based on experiences with Middle East Respiratory Syndrome and COVID-19 out- breaks in South Korea 3942
SARS-CoV-2 Biology Insights, Part I. Genome-wide structure and druggability: literature review 3943
SARS-CoV-2 Biology Insights, Part II. COVID-19 as a systemic persistent infection: narrative review. 3944
SARS-CoV-2 Biology Insights, Part III. The COVID-19 latency hypotheses and the fertility question. 3945
SARS-CoV-2 Biology Insights, Part IV.Antibody- Dependent Enhancement (ADE) and the tricky “Herd Immunity”: narrative review 3946
SARS-CoV-2 infection risk assessment in the endometrium: Viral infection-related gene expression across the menstrual cycle 3947
SARS-CoV-2 Serology Results in the First COVID-19 Case in California: A Case Report and Recommendations for Serology Testing and Interpretation 3948
SARS-Cov-2 trajectory predictions and scenario simulations from a global perspective: a modelling study 3949
Scientists in a time of COVID-19
Seroconversion in household members of COVID-19 outpatients  3951
Seroepidemiologic Study Designs for Determining SARS-COV-2 Transmission and Immunity 3952
Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity? 3953
Shock therapy to treat the Novel Coronavirus Disease (COVID-19) by ddNTPs 3954
Snapshot PCR Surveillance for SARS-CoV-2 in Hospital Staff in England 3955
Social Workers Must Address Intersecting Vulnerabilities among Noninstitutionalized, Black, Latinx, and Older Adults of Color during the COVID-19 Pandemic 3956
Spatial Disparities in Coronavirus Incidence and Mortality in the United States: An Ecological Analysis as of May 2020 3957
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts 3958
Spontaneous pneumothorax associated with COVID-19 3959
State power and the COVID-19 pandemic: the case of Finland 3960
Stroke care in Europe during the COVID-19 pandemic 3961
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease 3962
Superspreaders help covid-19 elimination David Kault, adjunct snr lect, maths, James Cook University and General Practitioner 3963
Survival Analysis of COVID-19 on Democracy with Cox Proportional Hazards Model 3964
Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay 3965
Targeting JAK-STAT Signaling to Control  Cytokine Release Syndrome in COVID-19 3966
Teledentistry during COVID-19 pandemic 3967
Tests with proven value in diagnosis of COVID-19 3968
The “Three Italy” of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering  complications other than pneumonia 3969
The American Heart Association COVID-19 CVD Registry Powered By Get With The Guidelines 3970
The broad-spectrum antiviral recommendations for drug discovery against COVID-19 3971
The Cardiac Toxicity of Chloroquine or Hydroxychloroquine in COVID-19 Patients: A Systematic Review and Meta-regression Analysis 3972
The COVID-19 pandemic: diverse contexts; different epidemics—how and why? 3973
The D614G mutation in SARS-CoV-2 Spike increases transduction of multiple human cell types 3974
The IMEx Coronavirus interactome: an evolving map of Coronaviridae-Host molecular interactions 3975
The Impact of COVID-19 Pandemic on Cardiology Services 3976
The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir  and sofosbuvir against SARS-CoV-2 3977
The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection 3978
The Interplay between Uric Acid, Mitochondrial Dysfunction, Vitamin D Deficiency, NLRP3  inflammasome activation, Inflammatory Disease, and Increased Susceptibility to COVID-19. 3979
The lung Tissue Microbiota Feature of Fatal COVID-19 3980
The potential effectiveness of Acetazolamide in the prevention of acute kidney injury in COVID-19 infection 3981
The Quiet Crisis of PhDs and COVID-19- Reaching the financial tipping point. 3982
The role of andrographolide and its derivative in COVID-19 associated proteins and immune system 3983
The U. S. COVID Economic Recovery Plan 3984
Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated  hyperinflammation: challenges and opportunities 3985
Time Dynamics of COVID-19 3986
TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients. 3987
To what Extent can the Legal Strategies employed to curb the Global Pandemic (Coronavirus) aid Climate Change and GlobalWarming Mitigation if transposed? 3988
Too little or too much? Missing the Goldilocks zone of hospital capacity during covid-19 3989
Transcriptogram analysis reveals relationship between viral titer and gene sets responses during Corona-virus infection. 3990
Transmission, Stability, Symptoms, Diagnosis and Management of COVID 19 3991
Undergraduate medical education and Covid-19: engaged but abstract 3992
Unraveling the SARS-CoV-2 Main Protease Mechanism Using Multiscale DFT/MM Methods 3993
Upper and Lower Airways Functional Examination in Asthma and Respiratory Allergic Deseases. Considerations in the SARS-CoV-2 Post- Pandemic Situation 3994
Use of N95, Surgical, and Cloth Masks to Prevent COVID-19 in Health Care and Community Settings: Living Practice Points From the American College of Physicians (Version 1) 3995
UV-C Irradiation Is Highly Effective in Inactivating and Inhibiting SARS-CoV-2 Replication 3996
Validation of the British Society of Thoracic Imaging guidelines for COVID-19 chest radiograph reporting 3997
Virus survival in evaporated saliva microdroplets deposited on inanimate surfaces 3998
Wakley Prize Essay 2020: medicine and plain truths in a pandemic year 3999
Wastewater monitoring of SARS-CoV-2: lessons from illicit drug policy 4000
What drives citizen engagement in government TikTok under public health emergencies——The case of Covid-19 Pandemic 4001
When to re-test- An examination of repeat COVID PCR patterns in an ambulatory population 4002
WHO statement- “Older people are at highest risk from COVID-19”: Should the hypothesis be corroborated or rejected? 4003
Association of mediastinal lymphadenopathy with COVID-19 prognosis  4004
Colorectal cancer screening in the USA in the wake of COVID-19 4005
COVID-19 pandemic reveals the peril of ignoring metadata standards 4006
COVID-19 revisiting inflammatory pathways of arthritis 4007
Endothelial dysfunction in Coronavirus disease 2019 (COVID-19): gender and age influences 4008
Engineered human mesenchymal stem cells as new vaccine platform for COVID-19 4009
Ethnic disparities in COVID-19 mortality: are comorbidities to blame? 4010
Exportin 1 inhibition as antiviral therapy 4011
Fatal SARS‑CoV‑2 infection in a renal transplant recipient 4012
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 4013
First environmental surveillance for the presence of SARS-CoV-2 RNA in wastewater and river water in Japan 4014
Gastrointestinal Manifestations in COVID- 19 Infection and Its Practical Applications 4015
Gut reaction: How the gut microbiome may influence the severity of COVID-19 4016
Haddon Matrix for Kidney Transplantation during COVID-19 Pandemic: A Problem Solving Framework for Present and Future 4017
Hydroxychloroquine and the treatment of Sjogren’s Syndrome, Chronic Ulcerative Stomatitis, and Oral Lichen Planus in the age of COVID-19 4018
Identification of Influential users on Twitter: A Novel Weighted Correlated Influence Measure for Covid-19 4019
Identifying a Kidney Transplant Recipient COVID Phenotype to Aid Test Utilization in the Setting of Limited Testing Availability - Does One Exist? 4020
Impact of Covid-19 on the treatment of acute myeloid leukemia 4021
Impact of Personal Protective Equipment on Surgical Performance During the COVID-19 Pandemic 4022
In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19 4023
Intussusception in an infant as a manifestation of COVID-19 4024
Is Increased Sleep Responsible for Reductions in Myocardial Infarction During the COVID-19 Pandemic? 4025
Kidney function on admission predicts in-hospital mortality in COVID-19 4026
Lockdown is not egalitarian: the costs fall on the global poor 4027
Low-Dose Radiation Therapy May Help COVID Patients 4028
Multivariate Analysis of Black Race and Environmental Temperature on COVID-19 In the US 4029
Neutralisation of SARS-CoV-2 by destruction of the prefusion Spike 4030
Ongoing clinical trials registered on clinicaltrials.gov for management of COVID-19. 4031
Overview of the COVID-19 and JAK/STAT Pathway Inhibition: Ruxolitinib Perspective 4032
Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19 4033
Preferences for scarce medical resource allocation: Differences between experts and the general public and implications for the COVID-19 pandemic 4034
Preventing COVID-19 from the perspective of industrial information integration: Evaluation and continuous improvement of information networks for sustainable epidemic prevention 4035
Rapidly fatal outcome of Covid-19 after successful emergency surgery during pandemic outbreak in Northern Italy 4036
Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: The THOCOoP cooperative group 4037
Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises 4038
Relationship between Chest CT manifestations and immune response in COVID-19 patients 4039
Reordering gender systems: can COVID-19 lead to improved gender equality and health? 4040
SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission 4041
SARS-CoV-2 E protein is a potential ion channel that can Be inhibited by Gliclazide and Memantine 4042
Spatial modelling, risk mapping, change detection, and outbreak trend analysis of coronavirus (COVID-19) in Iran (days between 19 February to 14 June 2020) 4043
Stemming the losses from COVID-19 4044
Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients 4045
The comparative politics of COVID-19: The need to understand government responses 4046
The Perfect Storm: How to Prepare against Climate Risk and Disaster Shocks in the Time of COVID-19 4047
Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof) 4048
US law enforcement crowd control tactics at anti-racism protests: a public health threat 4049
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids 4050
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2 4051
A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression 4052
Academic Emergency Medicine Physicians’ Anxiety Levels, Stressors and Potential Stress Mitigation Measures during the Acceleration Phase of the COVID-19 Pandemic 4053
Anti-cardiolipin IgG autoantibodies are an independent risk factor of COVID-19 severity 4054
Artificial intelligence in a crisis needs ethics with urgency 4055
Biological sex impacts COVID-19 outcomes 4056
Clinical epidemiological analyses of overweight/obesity and abnormal liver function contributing to  prolonged hospitalization in patients infected with COVID-19 4057
Comparative therapeutic efficacy of interferon and combination Kaletra plus interferon alpha-2b against SARS-CoV-2 4058
COVID-19 and Cardiac Arrhythmias 4060
COVID-19 lockdown allows researchers to quantify the effects of human activity on wildlife 4061
COVID-19 pneumonia diagnosis using a simple 2D deep learning framework with a single chest CT image 4062
COVID-19 Pneumonia: Inter-Observer Agreement and Diagnostic Accuracy of Chest CT in Patients with Intermediate Clinical Probability 4063
Critical role of type III interferon in controlling SARS-CoV-2 infection in human intestinal epithelial cells 4064
Current status of COVID-19 therapies and drug repositioning applications 4065
Discrimination Experience and Concern During COVID-19: Exploring the Roles of Risk Perception and Information Source Among US Asians 4066
Epitope-based Immunoinformatics Approach on Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus-2 4068
Goingback intime foran antibody tofightCOVID-19 4069
Groovy RNA polymerase 4070
Honey as a potential natural remedy against COVID-19: pharmacological insights and therapeutic promises 4071
Human–computer collaboration for skin cancer recognition 4072
Impact of COVID-19 on Neurological Manifestations: An Overview of Stroke Presentation in Pandemic. 4073
Implications of SARS CoV-2 positivity in amniotic membranes for ophthalmologists 4074
Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19  patients 4075
Invasive mechanical ventilation in a former preterm infant with COVID-19 4076
Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus 4077
Male genital damage in COVID-19 patients: Are available data relevant? 4078
Mass Spectrometric Identification of SARS-CoV-2 Proteins from Gargle Solution Samples of COVID-19 Patients 4079
Myocardial injury in patients with COVID-19 4080
N95 Usage During the COVID-19 Pandemic 4081
N-terminal domain (NTD) of SARS-CoV-2 spike- protein structurally resembles MERS-CoV NTD sialoside-binding pocket 4082
Paromomycin: a potential dual targeted drug effectively inhibits both Spike (S1) and Main Protease of COVID-19 4083
Predictive Data Mining Models for Novel Coronavirus (COVID‑19) Infected Patients’ Recovery 4084
What drives us to be (ir)responsible for our health during the COVID-19 pandemic? The role of personality, thinking styles and conspiracy mentality 4085
Rapid Development and Dissemination of a Computer Interpretable Guideline for COVID-19 4086
Recommendations for the Operation of Endoscopy Centers in the setting of the COVID19 pandemic – A WEO guidance document 4087
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and  coagulopathy 4088
Reshaping the future of ethnobiology research after the COVID-19 pandemic 4089
RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus 4090
SARS-CoV-2 induces a unique mitochondrial transcriptome signature 4091
Simulated sunlight decreases the viability of SARS- CoV-2 4092
Simulations help reduce the effects of a second wave of COVID-19 4093
Social Vulnerability and Equity: The Disproportionate Impact of COVID-19 4094
Socially Connected during COVID-19: Online social connections mediate the relationship between loneliness and positive coping strategies 4095
Independent review of emergency economic stimulus measures: Global Financial Crisis and COVID-19 4096
The end of social confinement and COVID-19 re-emergence risk 4097
The potential impacts of obesity on COVID-19 4098
Validation of a digital pathology system including remote review during the COVID-19 pandemic 4099
Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2 4100